Bibliography

Abbott, Alison. “The Plaque Plan.” Nature 456 (2008): 161–64.

Abraham, Carolyn. “Dementia Researchers Feel Blocked by Ottawa, Big Pharma, Medical Dogma.” Globe and Mail, September 17, 2010. http://www.theglobeandmail.com/life/health-and-fitness/dementia-researchers-feel-blocked-by-ottawa-big-pharma-medical-dogma/article4389415/.

Acosta-Baena, Natalia, Diego Sepulveda-Falla, Carlos Mario Lopera-Gómez, Mario César Jaramillo-Elorza, Sonia Moreno, Daniel Camilo Aguirre-Acevedo, Amanda Saldarriaga, and Francisco Lopera. “Pre-dementia Clinical Stages in Presenilin 1 E280A Familial Early-Onset Alzheimer’s Disease: A Retrospective Cohort Study.” The Lancet Neurology 10, no. 3 (2011): 213–20.

“Ageing Epidemic Looms in Ghana.” Modern Ghana, June 17, 2007. http://www.modernghana.com/news/137880/1/ageing-epidemic-looms-in-ghana.html.

Aizenstein, Howard Jay, Robert D. Nebes, Judith A. Saxton, Julie C. Price, Chester A. Mathis, Nicholas D. Tsopelas, Scott K. Ziolko, et al. “Frequent Amyloid Deposition without Significant Cognitive Impairment among the Elderly.” Archives of Neurology 65, no. 11 (2008): 1509–17.

Alliance for Human Research Protection. “NY Times Corrects Gina Kolata Re: Alzheimer’s.” September 16, 2010. http://www.ahrp.org/cms/content/view/726/1/.

Alzheimer’s Association, William Thies, and Laura Bleiler. “2011 Alzheimer’s Disease Facts and Figures.” Alzheimer’s & Dementia 7, no. 2 (2011): 208–44.

Alzheimer Society of Canada. “Alzheimer Care: Ethical Guidelines; Genetic Testing.” 2006. http://www.alzheimer.ca/english/care/ethics-genetictest.htm.

Alzheimer’s Association. Portraits From the Mind: The Works of William Utermohlen 1955–2000: A Retrospective of the Artist’s Work Before and After His Diagnosis with Alzheimer’s Disease. Salt Lake City, Utah: Myriad Pharmaceuticals, 2008.

Alzheimer’s Association International Conference. “Sleep Duration, Sleep Disorders, and Circadian Patterns Are Risk Factors and Indicators of Cognitive Decline.” Press release, 2012. http://www.alz.org/aaic/releases/mon_1030amct_irregular_sleep.asp.

“Alzheimer’s Disease: Amyloid Precursor Protein—Good, Bad or Both?” ScienceDaily, December 29, 2009. http://www.sciencedaily.com/releases/2009/10/091018171806.htm.

Alzheimer’s Disease International. World Alzheimer Report 2009: Executive Summary. 2009. http://www.alz.co.uk/research/files/WorldAlzheimerReport-ExecutiveSummary.pdf.

Amador-Ortiz, Catalina, Wen-Lang Lin, Zeshan Ahmed, David Personett, Peter Davies, Ranjan Duara, Neill R. Graff-Radford, Michael L. Hutton, and Dennis W. Dickson. “TDP-43 Immunoreactivity in Hippocampal Sclerosis and Alzheimer’s Disease.” Annals of Neurology 61, no. 5 (2007): 435–45.

Andersen, Erin. “Isolated by Affliction, Isolated by Language.” Globe and Mail, December 18, 2010.

Anderson, Warwick. The Collectors of Lost Souls: Turning Kuru Scientists into White Men. Baltimore: Johns Hopkins University Press, 2008.

Apse, Kira A., Barbara B. Biesecker, Francis M. Giardiello, Barbara P. Fuller, and Barbara A. Bernhardt. “Perceptions of Genetic Discrimination among At-Risk Relatives of Colorectal Cancer Patients.” Genetics in Medicine 6, no. 6 (2004): 510–16.

Ballenger, Jesse F. “DSM-V: Continuing the Confusion about Aging, Alzheimer’s and Dementia.” H-madness: History of Psychiatry, March 19, 2010. http://historypsychiatry.com/2010/03/19/dsm-v-continuing-the-confusion-about-aging-alzheimer%e2%80%99s-and-dementia/.

———. “Necessary Interventions: Antidementia Drugs and Heightened Expectations for Aging in Modern American Cultures and Society.” In Ballenger et al., Treating Dementia, 189–209.

———. Self, Senility, and Alzheimer’s Disease in Modern America: A History. Baltimore: Johns Hopkins University Press, 2006.

Ballenger, Jesse F., Peter Whitehouse, Constantine G. Lykestsos, Peter V. Rabins, and Jason H. T. Karlawish, eds. Treating Dementia: Do We Have a Pill for It? Baltimore: Johns Hopkins University Press, 2009.

Barad, Karen. Meeting the Universe Halfway: Quantum Physics and the Entanglement of Matter and Meaning. Durham, N.C.: Duke University Press, 2007.

Barboza, David. “China, in a Shift, Takes on Its Alzheimer’s Problem.” New York Times, January 12, 2011.

Barnes, Barry, and John Dupré. Genomes: And What to Make of Them. Chicago: University of Chicago Press, 2008.

Bateman, Randall, and John Morris. “The Dominantly Inherited Alzheimer’s Network Trials: An Opportunity to Prevent Alzheimer’s Disease.” Alzheimer’s & Dementia 8, no. 4 (2012): 427.

Bayley, John. Iris: A Memoir of Iris Murdoch. London: Abacus, 2002.

Beach, Thomas G. “The History of Alzheimer Disease: Three Debates.” Journal of the History of Medicine 42 (1987): 327–42.

Beck, Stefan, and Jörg Niewöhner. “Translating Genetic Testing and Screening in Cyprus and Germany: Contingencies, Continuities, Ordering Effects and Bio-Cultural Intimacy.” In The Handbook of Genetics & Society: Mapping the New Genomic Era, edited by Paul Atkinson, Peter Glasner, and Margaret Lock, 76–93. New York: Routledge, 2009.

Beck, Ulrich. World at Risk. Cambridge: Polity Press, 2007.

Beeson, Diane, and Theresa Doksum. “Family Values and Resistance to Genetic Testing.” In Bioethics in Social Context, edited by Barry Hoffmaster, 153–79. Philadelphia: Temple University Press, 2001.

Belluck, Pam. “Alzheimer’s Stalks a Columbian Family.” New York Times, June 1, 2010, Health sec. http://www.nytimes.com/2010/06/02/health/02alzheimers.html.

———. “New Drug Trial Seeks to Stop Alzheimer’s Before It Starts.” New York Times, May 15, 2012, Health/Research sec. http://www.nytimes.com/2012/05/16/health/research/prevention-is-goal-of-alzheimers-drug-trial.html.

Belluck, Pam, and Salvador Rodriguez. “Hoping to Crack Alzheimer’s, Together as a Family.” New York Times, October 3, 2011, Health sec. http://www.nytimes.com/2011/10/04/health/04alzheimers.html.

Bennett, David A., Philip L. De Jager, Sue E. Leurgans, and Julie A. Schneider. “Neuropathologic Intermediate Phenotypes Enhance Association to Alzheimer Susceptibility Alleles.” Neurology 72, no. 17 (2009): 1495–1503.

Bennett, I. J., E. J. Golob, E. S. Parker, and A. Starr. “Memory Evaluation in Mild Cognitive Impairment Using Recall and Recognition Tests.” Journal of Clinical and Experimental Neuropsychology 28, no. 8 (2006): 1408–22.

Berg, Marc. Rationalizing Medical Work: Decision-Support Techniques and Medical Practices. Cambridge, Mass.: MIT Press, 1997.

Berger, John. Ways of Seeing. London: Penguin, 1972.

Berrios, G. E. “Alzheimer Disease: A Conceptual History.” International Journal of Geriatric Psychiatry 5 (1990): 355–65.

Bertram, Lars, and Rudolph E. Tanzi. “Alzheimer’s Disease: One Disorder, Too Many Genes?” Human Molecular Genetics 13, no. 90001 (January 13, 2004): R135–R141.

Bertram, Lars, Christina M. Lill, and Rudolph E. Tanzi. “The Genetics of Alzheimer Disease: Back to the Future.” Neuron 68, no. 2 (2010): 270–81.

Bertram, Lars, and Rudolph E. Tanzi. “Genome-wide Association Studies in Alzheimer’s Disease.” Human Molecular Genetics 18, no. R2 (2009): 270–81.

Binstock, R., and S. G. Post, eds. Too Old for Health Care? Controversies in Medicine, Law, Economics, and Ethics. Baltimore: Johns Hopkins University Press, 1991.

Blacker, Deborah, and Rudolph E. Tanzi. “Genetic Testing in the Early Diagnosis of Alzheimer Disease.” In Scinto and Daffner, The Early Diagnosis of Alzheimer’s Disease, 105–26.

Borazanci, Aimee Pasqua, Meghan K. Harris, Robert N. Schwendimann, Eduardo Gonzalez-Toledo, Amir H. Maghzi, Masoud Etemadifar, Nadejda Alekseeva, James Pinkston, Roger E. Kelley, and Alireza Minagar. “Multiple Sclerosis: Clinical Features, Pathophysiology, Neuroimaging and Future Therapies.” Future Neurology 4, no. 2 (2009): 229–46.

Bowler, John V., David G. Munoz, Harold Merskey, and Vladimir Hachinski. “Fallacies in the Pathological Confirmation of the Diagnosis of Alzheimer’s Disease.” Journal of Neurology, Neurosurgery & Psychiatry 64, no. 1 (1998): 18–24.

Braak, H., and E. Braak. “Neuropathological Stageing of Alzheimer-Related Changes.” Journal of Neuropathology & Experimental Neurology 59 (2000): 733–48.

Brayne, Carol. “The Elephant in the Room—Healthy Brains in Later Life, Epidemiology and Public Health.” Nature Reviews Neuroscience 8, no. 3 (2007): 233–39.

———. “Research and Alzheimer’s Disease: An Epidemiological Perspective.” Psychological Medicine 23, no. 2 (1993): 287–96.

Brayne, Carol, and Paul Calloway. “Normal Ageing, Impaired Cognitive Function, and Senile Dementia of the Alzheimer’s Type: A Continuum?” The Lancet 331 (1988): 1265–67.

Brayne, Carol, and Daniel Davis. “Making Alzheimer’s and Dementia Research Fit for Populations.” The Lancet 380 (2012): 1441–43.

Brayne, Carol, Paul G. Ince, Hannah A. D. Keage, Ian G. McKeith, Fiona E. Matthews, Tuomo Polvikoski, and Raimo Sulkava. “Education, the Brain and Dementia: Neuroprotection or Compensation? EClipSE Collaborative Members.” Brain 133, no. 8 (2010): 2210–16.

Brayne, Carol, Blossom C. M. Stephan, and Fiona E. Matthews. “A European Perspective on Population Studies of Dementia.” Alzheimer’s & Dementia 7, no. 1 (2011): 3–9.

Breitner, John C. S. “Dementia—Epidemiological Considerations, Nomenclature, and a Tacit Consensus Definition.” Journal of Geriatric Psychiatry and Neurology 19, no. 3 (2006): 129–36.

Breteler, Monique. “Mapping Out Biomarkers for Alzheimer Disease.” Journal of the American Medical Association 305, no. 3 (2011): 304–5.

Brindle, David. “Older People Are an Asset, Not a Drain.” Guardian, March 2, 2011.

Brisbane, Arthur. “The Trouble with Absolutes.” New York Times, July 13, 2010, Public Editor’s Journal sec. http://publiceditor.blogs.nytimes.com/2010/08/24/the-trouble-with-absolutes/.

Brown, Theodore M. “Mental Diseases.” In Companion Encyclopedia of the History of Medicine, vol. 1, edited by W. F. Bynum and Roy Porter, 438–62. London: Routledge, 1993.

Buchanan, Anne V., Samuel Sholtis, Joan Richtsmeier, and Kenneth M. Weiss. “What Are Genes ‘for’ or Where Are Traits ‘from’? What Is the Question?” BioEssays 31, no. 2 (2009): 198–208.

Burchell, Graham, Colin Gordon, and Peter Miller, eds. The Foucault Effect: Studies in Governmentality. Hemel Hempstead: Harvester Wheatsheaf, 1991.

Butler, Robert. The Longevity Revolution: The Benefits and Challenges of Living a Long Life. New York: Public Affairs, 2008.

Butler, Robert N., Richard A. Miller, Daniel Perry, Bruce A. Carnes, T. Franklin Williams, Christine Cassel, Jacob Brody, et al. “New Model of Health Promotion and Disease Prevention for the 21st Century.” British Medical Journal 337 (2008): a399.

Callon, Michel, and Vololona Rabeharisoa. “Gino’s Lesson on Humanity: Genetics, Mutual Entanglements and the Sociologist’s Role.” Economy and Society 33, no. 1 (2004): 1–27.

Canadian Study of Health and Aging Working Group. “The Incidence of Dementia in Canada.” Neurology 55, no. 1 (2000): 66–73.

Canguilhem, Georges. The Normal and the Pathological. New York: Zone Books, 1991.

Carome, Michael, and Sidney Wolfe. “Florbetapir-pet Imaging and Postmortem Β-amyloid Pathology.” Journal of the American Medical Association 305, no. 18 (2011): 1857–58.

Cassels, Alan. “Drug Bust.” Common Ground, November 2010. http://www.commonground.ca/iss/232/cg232_cassels.shtml.

Castel, Robert. “From Dangerousness to Risk.” In Burchell, Gordon, and Miller, The Foucault Effect, 281–98.

Castellani, Rudy J., Hyoung-gon Lee, Sandra L. Siedlak, Akihiko Nunomura, Takaaki Hayashi, Masao Nakamura, Xiongwei Zhu, George Perry, and Mark A. Smith. “Reexamining Alzheimer’s Disease: Evidence for a Protective Role for Amyloid-β Protein Precursor and Amyloid-β.” Journal of Alzheimer’s Disease 18, no. 2 (2009): 447–52.

Chaufan, Claudia, Brooke Hollister, Jennifer Nazareno, and Patrick Fox. “Medical Ideology as a Double-Edged Sword: The Politics of Cure and Care in the Making of Alzheimer’s Disease.” Social Science & Medicine 74 (2012): 788–95.

Chilibeck, Gillian, Margaret Lock, and Megha Sehdev. “Postgenomics, Uncertain Futures, and the Familiarization of Susceptibility Genes.” Social Science & Medicine 72, no. 11 (2011): 1768–75.

Choudhury, Suparna, and Jan Slaby, eds. Critical Neuroscience: A Handbook of the Social and Cultural Contexts of Neuroscience. Chichester, UK: Wiley-Blackwell, 2012.

Christakis, N. A. “The Ellipsis of Prognosis in Modern Medical Thought.” Social Science & Medicine 44, no. 3 (1997): 301–15.

Churchland, Patricia. Brain-Wise: Studies in Neurophilosophy. Cambridge, Mass.: MIT Press, 2002.

Clark, C. M., and J. A. Schneider. “Use of Florbetapir-pet for Imaging Β-amyloid Pathology.” Journal of the American Medical Association 305, no. 3 (2011): 275–83.

Cohen, Lawrence. No Aging in India: Alzheimer’s, the Bad Family, and Other Modern Things. Berkeley: University of California Press, 1998.

Cohn, Simon. “Disrupting Images: Neuroscientific Representations in the Lives of Psychiatric Patients.” In Choudhury and Slaby, Critical Neuroscience, 179–94.

Cole, T. The Journey of Life: A Cultural History of Aging in America. Cambridge: Cambridge University Press, 1991.

“The Colombian Alzheimer’s Family Testing Possible Cures.” BBC News, May 19, 2011, Latin America & Caribbean sec. http://www.bbc.co.uk/news/world-latin-america-13428265.

Comfort, Alex. A Good Age. New York: Simon & Schuster, 1976.

Condit, C. M. “How the Public Understands Genetics: Non-Deterministic and Non-Discriminatory Interpretations of the ‘Blueprint’ Metaphor.” Public Understanding of Science 8, no. 3 (1999): 169–80.

Corbo, R. M., and R. Scacchi. “Apolipoprotein E (APOE) Allele Distribution in the World: Is APOEε4 a ‘Thrifty’ Allele?” Annals of Human Genetics 63 (1999): 301–10.

Corder, E. H., A. M. Saunders, W. J. Strittmatter, D. E. Schmechel, P. C. Gaskell, G. W. Small, A. D. Roses, J. L. Haines, and M. A. Pericak-Vance. “Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer’s Disease in Late Onset Families.” Science 261 (1993): 921–23.

Costandi, Mo. “Disrupted Sleep Might Signal Early Stages of Alzheimer’s.” Scientific American, October 18, 2012. http://www.scientificamerican.com/article.cfm?id=disrupted-sleep-might-signal-early-stages-of-alzheimers.

Cox, S., and W. McKellin. “ ‘There’s This Thing in Our Family’: Predictive Testing and the Construction of Risk for Huntington Disease.” In Sociological Perspectives on the New Genetics, edited by P. Conrad and J. Gabe, 121–48. London: Blackwell, 1999.

Cruchaga, Carlos, Sumitra Chakraverty, Kevin Mayo, Francesco L. M. Vallania, Robi D. Mitra, Kelley Faber, Jennifer Williamson, Tom Bird, Ramon Diaz-Arrastia, Tatiana M. Foroud, Bradley F. Boeve, Neill R. Graff-Radford, Pamela St. Jean, Michael Lawson, Margaret G. Ehm, Richard Mayeux, and Alison M. Goate. “Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer’s Disease Families.” PLoS ONE 7, no. 2 (2012): e31039.

Crutch, Sebastian J., Ron Isaacs, and Martin N. Rossor. “Some Workmen Can Blame Their Tools: Artistic Change in an Individual with Alzheimer’s Disease.” The Lancet 357 (2001): 2129–33.

Crystal, Howard A., Dennis Dickson, Peter Davies, David Masur, Ellen Grober, and Richard B. Lipton. “The Relative Frequency of ‘Dementia of Unknown Etiology’ Increases with Age and Is Nearly 50% in Nonagenarians.” Archives of Neurology 57, no. 5 (2000): 713–19.

Cupples, L. Adrienne, Lindsay A. Farrer, A. Dessa Sadovnick, Norman Relkin, Peter Whitehouse, and Robert C. Green. “Estimating Risk Curves for First-degree Relatives of Patients with Alzheimer’s Disease: The REVEAL Study.” Genetics in Medicine 6, no. 4 (2004): 192–96.

Daston, Lorraine. Classical Probability in the Enlightenment. Princeton: Princeton University Press, 1988.

Daston, Lorraine, and Peter Galison. Objectivity. New York: Zone Books, 2007.

Davis, D. G., F. A. Schmitt, D. R. Wekstein, and W. R. Markesbery. “Alzheimer Neuropathologic Alterations in Aged Cognitively Normal Subjects.” Journal of Neuropathology & Experimental Neurology 58, no. 4 (1999): 376–88.

Daxinger, Lucia, and Emma Whitelaw. “Understanding Transgenerational Epigenetic Inheritance via the Gametes in Mammals.” Nature Reviews Genetics 13, no. 3 (2012): 153–62.

Delvecchio Good, M. J., B. J. Good, C. Schaffer, and S. E. Lind. “American Oncology and the Discourse on Hope.” Culture, Medicine, and Psychiatry 14, no. 1 (1990): 59–79.

De Meyer, Geert, Fred Shapiro, Hugo Vanderstichele, Eugeen Vanmechelen, Sebastiaan Engelborghs, Peter Paul De Deyn, Els Coart, et al. “Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People.” Archives of Neurology 67, no. 8 (2010): 949–56.

Dickson, Samuel P., Kai Wang, Ian Krantz, Hakon Hakonarson, and David B. Goldstein. “Rare Variants Create Synthetic Genome-Wide Associations.” PLoS Biology 8, no. 1 (2010): e1000294.

Dillman, Konrad. “Epistemological Lessons from History.” In Whitehouse, Maurer, and Ballenger, Concepts of Alzheimer Disease, 129–57.

Dolinoy, Dana C., Radhika Das, Jennifer R. Weidman, and Randy L. Jirtle. “Metastable Epialleles, Imprinting, and the Fetal Origins of Adult Diseases.” Pediatric Research 61, no. 5, pt. 2 (2007): 30R–37R.

Douglas, Mary. “Risk as a Forensic Resource.” Daedalus 119, no. 4 (1990): 1–16.

Dubois, Bruno, Howard H. Feldman, Claudia Jacova, Steven T. DeKosky, Pascale Barberger-Gateau, Jeffrey Cummings, André Delacourte, et al. “Research Criteria for the Diagnosis of Alzheimer’s Disease: Revising the NINCDS-ADRDA Criteria.” The Lancet Neurology 6, no. 8 (2007): 734–46.

Dubois, Bruno, Howard H. Feldman, Claudia Jacova, Jeffrey L. Cummings, Steven T. Dekosky, Pascale Barberger-Gateau, André Delacourte, et al. “Revising the Definition of Alzheimer’s Disease: A New Lexicon.” The Lancet Neurology 9, no. 11 (2010): 1118–27.

Dubos, René. Mirage of Health. London: Harper and Row, 1959.

Dumit, Joseph. “Critically Producing Brain Images of Mind.” In Choudhury and Slaby, Critical Neuroscience, 195–226.

———. Picturing Personhood: Brain Scans and Biomedical Identity. Princeton: Princeton University Press, 2004.

Duden, B., and S. Samerki. “ ‘Pop Genes’: An Investigation of ‘the Gene’ in Popular Parlance.” In Biomedicine as Culture: Instrumental Practices, Technoscientific Knowledge, and New Modes of Life, edited by R. V. Burri and J. Dumit, 167–90. New York: Routledge, 2007.

Dupré, John. “The Polygenomic Organism.” In Nature After the Genome, edited by Sarah Parry and John Dupré, 19–31. Oxford: Blackwell, 2010.

Duster, Troy. Backdoor to Eugenics. New York: Routledge, 1990.

———. “Buried Alive: The Concept of Race in Science.” In Goodman, Heath, and Lindee, Genetic Nature/Culture, 258–77.

Duyckaerts, C., P. Delaère, J.-J. Hauw, A. L. Abbamondi-Pinto, S. Sorbi, I. Allen, J. P. Brion, et al. “Rating of the Lesions in Senile Dementia of the Alzheimer Type: Concordance between Laboratories. A European Multicenter Study under the Auspices of EURAGE.” Journal of the Neurological Sciences 97, nos. 2–3 (1990): 295–323.

Eddy, S. R. “Non-coding RNA Genes and the Modern RNA World.” Nature Reviews Genetics 2, no. 12 (2001): 919–29.

The Editors. “Alzheimer Disease.” Nature Medicine 12, no. 7 (2006): 746–84.

Ekstein, J., and H. Katzenstein. “The Dor Yeshorim Story: Community-Based Carrier Screening for Tay-Sachs Disease.” Advances in Genetics 44 (2001): 297–310.

Emslie, C., K. Hunt, and G. Watt. “A Chip Off the Old Block? Lay Understandings of Inheritance amongst Men and Women in Mid-life.” Public Understanding of Science 12, no. 1 (2003): 47–65.

Engstrom, Eric. “Researching Dementia in Imperial Germany: Alois Alzheimer and the Economies of Psychiatric Practice.” Culture, Medicine, and Psychiatry 31, no. 3 (2007): 405–13.

Erkinjuntti, T., T. Ostbye, R. Steenhuis, and V. Hachinski. “The Effect of Different Diagnostic Criteria on the Prevalence of Dementia.” New England Journal of Medicine 337, no. 23 (1997): 1667–74.

Erlich, S. S., and R. L. Davis. “Alzheimer’s Disease in the Very Aged.” Journal of Neuropathology & Experimental Neurology 39, no. 3 (1980): 352–54.

Evans-Pritchard, E. E. Witchcraft, Oracles and Magic among the Azande. Oxford: Clarendon, 1937.

Ewald, François. “Insurance and Risk.” In Burchell, Gordon, and Miller, The Foucault Effect, 197–210.

Ezrati, Milton. “Japan’s Aging Economics.” Foreign Affairs, May/June 1997. http://www.foreignaffairs.com/articles/53050/milton-ezrati/japans-aging-economics.

Farlow, Martin R. “Alzheimer’s Disease: Clinical Implications of the Apolipoprotein E Genotype.” Neurology 48, no. 5, suppl. 6 (1997): S30–S34.

Farrer, L. A. “Familial Risk for Alzheimer Disease in Ethnic Minorities: Nondiscriminating Genes.” Archives of Neurology 57, no. 1 (2000): 28–29.

———. “Intercontinental Epidemiology of Alzheimer Disease: A Global Approach to Bad Gene Hunting.” Journal of the American Medical Association 285, no. 6 (2001): 796–98.

Farrer, L. A., L. A. Cupples, J. L. Haines, B. Hyman, W. A. Kukull, R. Mayeux, R. H. Myers, M. A. Pericak-Vance, N. Risch, and C. M. van Duijn. “Effects of Age, Sex, and Ethnicity on the Association between Apolipoprotein E Genotype and Alzheimer Disease. A Meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.” Journal of the American Medical Association 278, no. 16 (1997): 1349–56.

Fassin, Didier. “Another Politics of Life Is Possible.” Theory, Culture & Society 26, no. 5 (2009): 44–60.

Featherstone, Katie, Paul Atkinson, Aditva Bharadwai, and Angus Clarke. Risky Relations: Family, Kinship and the New Genetics. Oxford: Berg, 2006.

Finch, C. E., and R. M. Sapolsky. “The Evolution of Alzheimer Disease, the Reproductive Schedule, and apoE Isoforms.” Neurobiology of Aging 20, no. 4 (1999): 407–28.

Fleck, Ludwik. Genesis and Development of a Scientific Fact. Chicago: University of Chicago Press, 1979.

Fleisher, Adam S., Kewei Chen, Yakeel T. Quiroz, Laura J. Jakimovich, Madelyn Gutierrez Gomez, Carolyn M. Langois, Jessica B. S. Langbaum, Napatkamon Ayutyanont, Auttawut Roontiva, Pradeep Thiyyagura, Wendy Lee, Hua Mo, Liliana Lopez, Sonia Moreno, Natalia Acosta-Baena, Margarita Giraldo, Gloria Garcia, Rebecca A. Reiman, Matthew J. Huentelman, Kenneth S. Kosik, Pierre N. Tariot, Francisco Lopera, and Eric M. Reiman. “Florbetapir PET Analysis of Amyloid-β Deposition in the Presenilin 1 E280A Autosomal Dominant Alzheimer’s Disease Kindred: A Cross-Sectional Study.” The Lancet Neurology 11 (2012): 1057–65.

Folstein, M. F., S. E. Folstein, and P. R. McHugh. “ ‘Mini-mental State’: A Practical Method for Grading the Cognitive State of Patients for the Clinician.” Journal of Psychiatric Research 12, no. 3 (1975): 189–98.

Foucault, Michel. The Birth of the Clinic: An Archaeology of Medical Perception. Translated by A. M. Sheridan Smith. New York: Vintage Books, 1973.

———. The History of Sexuality. Vol. 1. New York: Vintage Books, 1980.

Fox, Nick. “When, Where, and How Does Alzheimer’s Disease Start?” The Lancet Neurology 11 (2012): 1017–18.

Fox, Patrick. “From Senility to Alzheimer Disease: The Rise of the Alzheimer Disease Movement.” Milbank Quarterly 67 (1989): 58–102.

———. “The Role of the Concept of Alzheimer Disease.” In Whitehouse, Maurer, and Ballenger, Concepts of Alzheimer Disease, 209–33.

Franklin, Sarah. “Life.” In The Encyclopedia of Bioethics, edited by Warren T. Reich, 456–62. New York: Simon & Schuster, 1995.

Franzen, Jonathan. “My Father’s Brain.” The New Yorker, September 10, 2001.

Fullerton, Stephanie M., Andrew G. Clark, Kenneth M. Weiss, Deborah A. Nickerson, Scott L. Taylor, Jari H. Stengård, Veikko Salomaa, Erkki Vartiainen, Markus Perola, Eric Boerwinkle, and Charles F. Sing. “Apolipoprotein E Variation at the Sequence Haplotype Level: Implications for the Origin and Maintenance of a Major Human Polymorphism.” American Journal of Human Genetics 67, no. 4 (2000): 881–900.

Fullwiley, Duana. The Enculturated Gene: Sickle Cell Health Politics and Biological Difference in West Africa. Princeton: Princeton University Press, 2012.

Gaines, Atwood, and Peter Whitehouse. “Building a Mystery: Alzheimer Disease, Mild Cognitive Impairment, and Beyond.” Philosophy, Psychiatry, & Psychology 13 (2006): 61–74.

Galerie Beckel-Odille-Boïcos. William Utermohlen: Paintings and Drawings 1955–1997. Paris, 2000.

———. William Utermohlen Œuvres: 1955–1997. Paris, 2002.

Galison, Peter, and David Stump, eds. The Disunity of Science—Boundaries, Contexts, and Power. Stanford: Stanford University Press, 1996.

Garnick, Marc B. “The Great Prostate Cancer Debate.” Scientific American 306, no. 2 (2012): 38–43.

Garrard, Peter, Lisa M. Maloney, John R. Hodges, and Karalyn Patterson. “The Effects of Very Early Alzheimer’s Disease on the Characteristics of Writing by a Renowned Author.” Brain 128, no. 2 (2005): 250–60.

Gauthier, Serge, Barry Reisberg, Michael Zaudig, Ronald C. Petersen, Karen Ritchie, Karl Broich, Sylvie Belleville, et al. “Mild Cognitive Impairment.” Lancet 367 (2006): 1262–70.

Gearing, M., G. W. Rebeck, B. T. Hyman, J. Tigges, and S. S. Mirra. “Neuropathology and Apolipoprotein E Profile of Aged Chimpanzees: Implications for Alzheimer Disease.” Neurobiology, Proceedings of the National Academy of Sciences of the United States of America 91, no. 20 (1994): 9382–86.

George, Daniel R. “Overcoming the Social Death of Dementia through Language.” The Lancet 376 (2010): 586–87.

George, Danny, and Peter Whitehouse. “The Classification of Alzheimer Disease and Mild Cognitive Impairment.” In Ballenger et al., Treating Dementia, 5–24.

George, Danny, Peter Whitehouse, Simon d’Alton, and Jesse Ballinger. “Through the Amyloid Gateway.” The Lancet 380 (2012): 1986–87.

Gere, Cathy. “ ‘Nature’s Experiment’: Epilepsy, Localization of Brain Function and the Emergence of the Cerebral Subject.” In Ortega and Vidal, Neurocultures, 235–47.

Ghebranious, Nader, Lynn Ivacic, Jamie Mallum, and Charles Dokken. “Detection of ApoE E2, E3 and E4 Alleles Using MALDI-TOF Mass Spectrometry and the Homogeneous Mass-Extend Technology.” Nucleic Acids Research 33, no. 17 (2005): e149.

Gibbon, Sarah, and Carlos Novas, eds. Biosocialities, Genetics and the Social Sciences: Making Biologies and Identities. London: Routledge, 2007.

Gilbert, Scott F. “The Genome in Its Ecological Context: Philosophical Perspectives on Interspecies Epigenesis.” Annals of the New York Academy of Sciences 981 (2002): 202–18.

Gilbert, Walter. “A Vision of the Grail.” In The Code of Codes: Scientific and Social Issues in the Human Genome Project, edited by Daniel Kevles and Leroy Hood, 83–97. Cambridge, Mass.: Harvard University Press, 1992.

Gilleard, C. J. “Is Alzheimer’s Disease Preventable? A Review of Two Decades of Epidemiological Research.” Aging and Mental Health 4 (2000): 101–18.

Glass, Daniel J., and Steven E. Arnold. “Some Evolutionary Perspectives on Alzheimer’s Disease Pathogenesis and Pathology.” Alzheimer’s & Dementia 8, no. 4 (2012): 343–50.

Gleckman, Howard. “The Obama Administration’s War on Alzheimer’s.” Forbes, January 11, 2012. http://www.forbes.com/sites/howardgleckman/2012/01/11/the-obama-administrations-war-on-alzheimers/.

Glenner, G. G. “Alzheimer’s Disease: The Commonest Form of Amyloidosis.” Archives of Pathology & Laboratory Medicine 107, no. 6 (1983): 281–82.

Goate, A., M. C. Chartier-Harlin, M. Mullan, J. Brown, F. Crawford, L. Fidani, L. Giuffra, A. Haynes, N. Irving, and L. James. “Segregation of a Missense Mutation in the Amyloid Precursor Protein Gene with Familial Alzheimer’s Disease.” Nature 349 (1991): 704–6.

Goldman, Jill S., Susan E. Hahn, Jennifer Williamson Catania, Susan LaRusse-Eckert, Melissa Barber Butson, Malia Rumbaugh, Michelle N. Strecker, et al. “Genetic Counseling and Testing for Alzheimer Disease: Joint Practice Guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors.” Genetics in Medicine 13, no. 6 (2011): 597–605.

Golomb, James, Alan Kluger, and Steven H. Ferris. “Mild Cognitive Impairment: Historical Development and Summary of Research.” Dialogues in Clinical Neuroscience 6, no. 4 (2004): 351–67.

Goodman, Alan H., Deborah Heath, and M. Susan Lindee, eds. Genetic Nature/Culture: Anthropology and Science beyond the Two Culture Divide. Berkeley: University of California Press, 2003.

Gottesman, I. I. “Schizophrenia Epigenesis: Past, Present, and Future.” Acta Psychiatrica Scandinavica. Supplementum 384 (1994): 26–33.

Graff-Radford, Neill R., Robert C. Green, Rodney C. P. Go, Michael L. Hutton, Timi Edeki, David Bachman, Jennifer L. Adamson, et al. “Association between Apolipoprotein E Genotype and Alzheimer Disease in African American Subjects.” Archives of Neurology 59, no. 4 (2002): 594–600.

Graham, Janice E., Kenneth Rockwood, B. Lynn Beattie, Ian McDowell, Robin Eastwood, and Serge Gauthier. “Standardization of the Diagnosis of Dementia in the Canadian Study of Health and Aging.” Neuroepidemiology 15, no. 5 (1996): 246–56.

Gravitz, Lauren. “Drugs: A Tangled Web of Targets.” Nature 475 (2011): S9–S11.

Green, Robert C., V. C. Clarke, N. J. Thompson, J. L. Woodard, and R. Letz. “Early Detection of Alzheimer Disease: Methods, Markers, and Misgivings.” Alzheimer Disease & Associated Disorders 11, suppl. 5 (1997): S1–S5, discussion S37–S39.

Green, Robert C., J. Scott Roberts, L. Adrienne Cupples, Norman R. Relkin, Peter J. Whitehouse, Tamsen Brown, Susan LaRusse Eckert, et al. “Disclosure of APOE Genotype for Risk of Alzheimer’s Disease.” New England Journal of Medicine 361, no. 3 (2009): 245–54.

Green, Robert, Scott Roberts, Jason Karlawish, Thomas Obisesan, L. Adrienne Cupples, Denise Lautenbach, Margaret Bradbury, et al. “Disclosure of APOE Genotype to Persons with Mild Cognitive Impairment (MCI).” Alzheimer’s & Dementia 8, no. 4 (2012): 423.

Greicius, Michael D., Gaurav Srivastava, Allan L. Reiss, and Vinod Menon. “Default-Mode Network Activity Distinguishes Alzheimer’s Disease from Healthy Aging: Evidence from Functional MRI.” Proceedings of the National Academy of Sciences of the United States of America 101, no. 13 (2004): 4637–42.

Griffiths, Paul E. “Developmental Systems Theory.” In Nature Encyclopedia of the Life Sciences, 1. London: John Wiley, 2002.

Growdon, John H. “Apolipoprotein E and Alzheimer Disease.” Archives of Neurology 55, no. 8 (1998): 1053–54.

Guan, Ji-Song, Stephen J. Haggarty, Emanuela Giacometti, Jan-Hermen Dannenberg, Nadine Joseph, Jun Gao, Thomas J. F. Nieland, et al. “HDAC2 Negatively Regulates Memory Formation and Synaptic Plasticity.” Nature 459 (2009): 55–60.

Guerreiro, Rita, Aleksandra Wojtas, Jose Bras, Minerva Carrasquillo, Ekaterina Rogaeva, Elisa Majounie, Carlos Cruchaga, Celeste Sassi, John S. K. Kauwe, Steven Younkin, Lilinaz Hazrati, John Collinge, Jennifer Pocock, Tammaryn Lashley, Julie Williams, Jean-Charles Lambert, Philippe Amouyel, Alison Goate, Rosa Rademakers, Kevin Morgan, John Powell, Peter St George-Hyslop, Andrew Singleton, and John Hardy. “Trem2 Variants in Alzheimer’s Disease.” New England Journal of Medicine 368 (November 14, 2012): 117–27.

Gureje, Oye, Adesola Ogunniyi, and Lola Kola. “The Profile and Impact of Probable Dementia in a Sub-Saharan African Community: Results from the Ibadan Study of Aging.” Journal of Psychosomatic Research 61, no. 3 (2006): 327–33.

Hacking, Ian. “Introduction.” In Thomas Kuhn, The Structure of Scientific Revolutions, 50th Anniversary ed., vii–xxxvii. Chicago: University of Chicago Press, 2012.

———. “The Looping Effects of Human Kinds.” In Causal Cognition: A Multidisciplinary Approach, edited by D. Sperber, D. Premack, and A. J. Premack, 351–83. Oxford: Oxford Medical Publications, 1995.

———. “Making up People.” In Reconstructing Individualism: Autonomy, Individuality, and the Self in Western Thought, edited by T. C. Heller, M. Sosna, and D. E. Wellberry, 222–36. Stanford: Stanford University Press, 1986. http://www.icesi.edu.co/blogs/antro_conocimiento/files/2012/02/Hacking_making-up-people.pdf.

———. The Taming of Chance. Cambridge: Cambridge University Press, 1990.

Hallowell, Nina. “Doing the Right Thing: Genetic Risk and Responsibility.” Sociology of Health & Illness 21, no. 5 (1999): 597–621.

Hampel, Harald, Simone Lista, and Zaven S. Khachaturian. “Development of Biomarkers to Chart All Alzheimer’s Disease Stages: The Royal Road to Cutting the Therapeutic Gordian Knot.” Alzheimer’s & Dementia 8, no. 4 (2012): 312–36.

Haraway, Donna J. Simians, Cyborgs, and Women: The Reinvention of Nature. New York: Routledge, 1991.

Harding, J. E. “The Nutritional Basis of the Fetal Origins of Adult Disease.” International Journal of Epidemiology 30, no. 1 (2001): 15–23.

Hardy, John A. “The Amyloid Cascade Hypothesis Has Misled the Pharmaceutical Industry.” Biochemical Society Transactions 39, no. 4 (2011): 920–23.

———. “ApoE, Amyloid, and Alzheimer’s Disease.” Science 263 (1994): 454–55.

Hardy, John A., and Dennis J. Selkoe. “The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics.” Science 297 (2002): 353–56.

Hardy, John A., and Gerald A. Higgins. “Alzheimer’s Disease: The Amyloid Cascade Hypothesis.” Science 256 (1992): 184–85.

Hayden, Kathleen M., Peter P. Zandi, Constantine G. Lyketsos, Ara S. Khachaturian, Lori A. Bastian, Gene Charoonruk, JoAnn T. Tschanz, et al. “Vascular Risk Factors for Incident Alzheimer Disease and Vascular Dementia: The Cache County Study.” Alzheimer Disease & Associated Disorders 20, no. 2 (2006): 93–100.

Heath, Deborah, and Karen-Sue Taussig. “Genetic Citizenship.” In A Companion to the Anthropology of Politics, edited by D. Nguyent and J. Vincent, 152–67. London: Blackwell, 2004.

Heinik, Jeremia. “V. A. Kral and the Origins of Benign Senescent Forgetfulness and Mild Cognitive Impairment.” International Psychogeriatrics 22, no. 3 (2010): 395–402.

Hendrie, Hugh. “Diagnosis of Dementia and Alzheimer’s Disease in Indianapolis and Ibadan: Challenges in Cross-Cultural Studies of Aging and Dementia.” Alzheimer’s & Dementia 5, no. 4 (2009): P122.

Herskovits, A. Zara, and John H. Growdon. “Sharpen That Needle.” Archives of Neurology 67, no. 8 (2010): 918–20.

Herskovits, E. “Struggling over Subjectivity: Debates about the ‘Self’ and Alzheimer Disease.” Medical Anthropology Quarterly 9 (1996): 146–64.

Heyman, J. C., M. L. Barer Hertzman, and R. G. Evans, eds. Healthier Societies: From Analysis to Action. Oxford: Oxford University Press, 2006.

Hill, Shirley. Managing Sickle Cell Disease in Low-Income Families. Philadelphia: Temple University Press, 1994.

Holmes, Clive. “The Genetics of Alzheimer’s Disease.” Menopause International 8, no. 1 (2002): 20–23.

Holmes, Clive, Delphine Boche, David Wilkinson, Ghasem Yadegarfar, Vivienne Hopkins, Anthony Bayer, Roy W. Jones, et al. “Long-Term Effects of Aβ42 Immunisation in Alzheimer’s Disease: Follow-Up of a Randomised, Placebo-Controlled Phase I Trial.” The Lancet 372 (2008): 216–23.

Holstein, Martha. “Alzheimer Disease and Senile Dementia, 1885–1920: An Interpretive History of Disease Negotiation.” Journal of Aging Studies 11 (1997): 1–13.

House of Lords. Science and Technology Committee: 6th Report. London: Parliament, 2006. http://www.publications.parliament.uk/pa/ld200506/ldselect/ldsctech/146/14603.htm.

Hughes, Charles. “Insanity Defined on the Basis of Disease.” The Alienist and Neurologist 20 (1887): 170–74.

Hughes, Julian C., Stephen J. Louw, and Steven R. Sabat. Dementia: Mind, Meaning, and the Person. Oxford: Oxford University Press, 2006.

Huppert, Felicia A., Carol Brayne, and Daniel W. O’Conner, eds. Dementia and Normal Aging. Cambridge: Cambridge University Press, 1994.

Hyman, Bradley T. “Alzheimer’s Disease or Alzheimer’s Diseases? Clues from Molecular Epidemiology.” Annals of Neurology 40, no. 2 (1996): 135–36.

Hyman, Bradley T., Creighton H. Phelps, Thomas G. Beach, Eileen H. Bigio, Nigel J. Cairns, Maria C. Carrillo, Dennis W. Dickson, et al. “National Institute on Aging–Alzheimer’s Association Guidelines for the Neuropathologic Assessment of Alzheimer’s Disease.” Alzheimer’s & Dementia 8, no. 1 (2012): 1–13.

Ignatieff, Michael. Scar Tissue. London: Chatto & Windus, 1993.

Ikels, Charlotte. “The Experience of Dementia in China.” Culture, Medicine, and Psychiatry 22 (1998): 257–83.

“Iris Murdoch’s Last Novel Reveals First Signs of Alzheimer’s Disease.” UCL News, December 1, 2004. http://www.ucl.ac.uk/news/news-articles/news-releases-archive/murdoch.

Jablonka, Eva, and Marion J. Lamb. Evolution in Four Dimensions: Genetic, Epigenetic, Behavioral, and Symbolic Variation in the History of Life. Cambridge, Mass.: MIT Press, 2005.

Jack, Clifford R., Jr., Marilyn S. Albert, David S. Knopman, Guy M. McKhann, Reisa A. Sperling, Maria C. Carrillo, Bill Thies, and Creighton H. Phelps. “Introduction to the Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease.” Alzheimer’s & Dementia 7, no. 3 (2011): 257–62.

Jack, Clifford R., Val J. Lowe, Stephen D. Weigand, Heather J. Wiste, Matthew L. Senjem, David S. Knopman, Maria M. Shiung, et al. “Serial PIB and MRI in Normal, Mild Cognitive Impairment and Alzheimer’s Disease: Implications for Sequence of Pathological Events in Alzheimer’s Disease.” Brain 132, no. 5 (2009): 1355–65.

Jackson, Richard, and Neil Howe. The Graying of the Middle Kingdom: The Demographics and Economics of Retirement Policy in China. Washington, D.C.: Center for Strategic & International Studies, 2004. http://csis.org/files/media/csis/pubs/grayingkingdom.pdf.

Jackson, Richard, Keisuke Nakashima, and Neil Howe. China’s Long March to Retirement Reform: The Graying of the Middle Kingdom Revisited. Washington, D.C.: Center for Strategic & International Studies, 2009. http://csis.org/files/media/csis/pubs/090422_gai_chinareport_en.pdf.

Jagust, William. “Aging, Amyloid and Neural Activity.” Alzheimer’s & Dementia 8, no. 4 (2012): 427.

———. “Tracking Brain Amyloid-β in Presymptomatic Alzheimer’s Disease.” The Lancet Neurology 11 (2012): 1018–20.

Jagust, W. J., S. M. Landau, L. M. Shaw, J. Q. Trojanowski, R. A. Koeppe, E. M. Reiman, N. L. Foster, et al. “Relationships between Biomarkers in Aging and Dementia.” Neurology 73, no. 15 (2009): 1193–99.

Jasen, Patricia. “Breast Cancer and the Language of Risk, 1750–1950.” Social History of Medicine 15, no. 1 (2002): 17–43.

Jilek, Wolfgang. “Emil Kraepelin and Comparative Sociocultural Psychiatry.” European Archives of Psychiatry and Clinical Neuroscience 245 (1995): 231–38.

Jonsson, Thorlakur, Jasvinder K. Atwal, Stacy Steinberg, Jon Snaedal, Palmi V. Jonsson, Sigurbjorn Bjornsson, Hreinn Stefansson, et al. “A Mutation in APP Protects Against Alzheimer’s Disease and Age-Related Cognitive Decline.” Nature 488 (2012): 96–99.

Jonsson, Thorlakur, Hreinn Stefansson, Stacy Steinberg, Ingileif Jonsdottir, Palmi V. Jonsson, Jon Snaedal, Sigurbjorn Bjornsson, Johanna Huttenlocher, Allan I. Levey, James J. Lah, Dan Rujescu, Harald Hampel, Ina Giegling, Ole A. Andreassen, Knut Engedal, Ingun Ulstein, Srdjan Djurovic, Carla Ibrahim-Verbaa, Albert Hofman, M. Arfan Ikram, Cornelia M. van Duijn, Unnur Thorsteinsdottir, Augustine Kong, and Kari Stefansson. “Variant of TREM2 Associated with the Risk of Alzheimer’s Disease.” New England Journal of Medicine 368 (November 14, 2012): 107–16. doi:10.1056/NEJMoa1211103

Kamboh, M. I. “Apolipoprotein E Polymorphism and Susceptibility to Alzheimer’s Disease.” Human Biology 67, no. 2 (1995): 195–215.

Karlawish, Jason. “Disclosing Amyloid Imaging Results.” Alzheimer’s & Dementia 8, no. 4 (2012): 423.

Karran, Eric, Marc Mercken, and Bart De Strooper. “The Amyloid Cascade Hypothesis for Alzheimer’s Disease: An Appraisal for the Development of Therapeutics.” Nature Reviews Drug Discovery 10, no. 9 (2011): 698–712.

Katzman, Robert. “The Prevalence and Malignancy of Alzheimer Disease: A Major Killer.” Archives of Neurology 33 (1976): 217–18.

Katzman, Robert, and Katherine L. Bick. “The Rediscovery of Alzheimer Disease in the 1960s and 1970s.” In Whitehouse, Maurer, and Ballenger, Concepts of Alzheimer Disease, 104–14.

Kaufman, Sharon. … And a Time to Die: How American Hospitals Shape the End of Life. New York: Scribner, 2005.

Kaufman, Sharon, Julie Livingston, Hong Zhang, and Margaret Lock. “Transforming the Concepts of Aging: Three Case Studies from Anthropology.” In Oxford Textbook of Old Age Psychiatry, edited by Tom Dening and Alan Thomas. 39–55. Oxford: Oxford University Press,

Kavanagh, Anne M., and Dorothy H. Broom. “Embodied Risk: My Body, Myself?” Social Science & Medicine 46, no. 3 (1998): 437–44.

Keating, Peter, and Alberto Cambrosio. Biomedical Platforms: Realigning the Normal and the Pathological in Late-Twentieth-Century Medicine. Cambridge, Mass.: MIT Press, 2003.

Keller, Evelyn Fox. The Century of the Gene. Cambridge, Mass.: Harvard University Press, 2000.

———. The Mirage of a Space between Nature and Nurture. Durham, N.C.: Duke University Press, 2010.

Keller, Matthew C., and Geoffrey Miller. “Resolving the Paradox of Common, Harmful, Heritable Mental Disorders: Which Evolutionary Genetic Models Work Best?” Behavioral Brain Science 29, no. 4 (2006): 385–452.

Kerr, Anne, Sarah Cunningham-Burley, and Amanda Amos. “The New Genetics and Health: Mobilizing Lay Expertise.” Public Understanding of Science 7, no. 1 (1998): 41–60.

Kertzer, David L., and Peter Laslett. Aging in the Past: Demography, Society and Old Age. Berkeley: University of California Press, 1995.

Khachaturian, Ara S., Michelle M. Mielke, and Zaven S. Khachaturian. “Biomarker Development: A Population-Level Perspective.” Alzheimer’s & Dementia 8, no. 4 (2012): 247–49.

Khachaturian, Zaven S. “Diagnosis of Alzheimer’s Disease.” Archives of Neurology 42, no. 11 (1985): 1097–1105.

Khachaturian, Zaven S. “Perspective on the Alzheimer’s Disease Neuroimaging Initiative: Progress Report and Future Plans.” Alzheimer’s & Dementia 6, no. 3 (2010): 199–201.

———. “Plundered Memories.” The Sciences 37, no. 4 (1997): 20–23.

Khachaturian, Zaven S., and Ara S. Khachaturian. “Prevent Alzheimer’s Disease by 2020: A National Strategic Goal.” Alzheimer’s & Dementia 5, no. 2 (2009): 81–84.

Kier, Frederick J., and Victor Molinari. “ ‘Do-It-Yourself’ Dementia Testing: Issues Regarding an Alzheimer’s Home Screening Test.” The Gerontologist 43, no. 3 (2003): 295–301.

Kirkwood, Tom. Time of Our Lives: The Science of Human Aging. Oxford: Oxford University Press, 1999.

Kitwood, Tom. Dementia Reconsidered: The Person Comes First. Maidenhead: Open University Press, 1997.

Klunk, William E., Henry Engler, Agneta Nordberg, Yanming Wang, Gunnar Blomqvist, Daniel P. Holt, Mats Bergström, et al. “Imaging Brain Amyloid in Alzheimer’s Disease with Pittsburgh Compound-B.” Annals of Neurology 55, no. 3 (2004): 306–19.

Kolata, Gina. “Alzheimer’s Tied to Mutation Harming Immune Response.” New York Times, November 14, 2012.

———. “Drug Trials Test Bold Plan to Slow Alzheimer’s.” New York Times, July 16, 2010.

———. “Early Tests for Alzheimer’s Pose Diagnosis Dilemma.” New York Times, December 17, 2010.

———. “F.D.A. Sees Promise in Alzheimer’s Imaging Drug.” New York Times, January 20, 2011.

———. “Finding Suggests New Target for Alzheimer’s Drugs.” New York Times, September 1, 2010.

———. “Guidelines Seek Early Detection of Alzheimer’s.” New York Times, July 14, 2010. http://query.nytimes.com/gst/fullpage.html?res=9F06E6D91F3AF937A25754C0A9669D8B6.

———. “In Preventing Alzheimer’s, Mutation May Aid Drug Quest.” New York Times, July 11, 2012.

———. “In Spinal-Fluid Test, an Early Warning on Alzheimer’s.” New York Times, August 9, 2010.

———. “Insights Give New Hope for New Attack on Alzheimer’s.” New York Times, December 13, 2010.

———. “New Scan May Spot Alzheimer’s.” New York Times, July 13, 2010.

———. “Rare Sharing of Data Led to Results on Alzheimer’s.” New York Times, August 12, 2010, Health/Research sec. http://www.nytimes.com/2010/08/13/health/research/13alzheimer.html.

———. “Vast Gene Study Yields Insights on Alzheimer’s.” New York Times, April 3, 2011.

Konrad, Monica. Narrating the New Predictive Genetics: Ethics, Ethnography, and Science. Cambridge: Cambridge University Press, 2005.

Kuhn, Thomas. The Structure of Scientific Revolutions. Chicago: University of Chicago Press, 1962.

Lambek, Michael. Knowledge and Practice in Mayotte: Local Discourses of Islam, Sorcery and Spirit Possession. Toronto: Toronto University Press, 1993.

Landecker, Hannah. Culturing Life: How Cells Became Technologies. Cambridge, Mass.: Harvard University Press, 2007.

Langreth, Robert. “Eli Lilly Alzheimer’s Disease Failure Bolsters Amyloid Theory Skeptics—Forbes.” Forbes, August 17, 2010. http://www.forbes.com/sites/robertlangreth/2010/08/17/eli-lilly-alzheimers-failure-bolsters-skeptics-on-amyloid-theory/.

Larusse, Susan, J. Scott Roberts, Theresa M. Marteau, Heather Katsen, Erin L. Linnenbringer, Melissa Barber, Peter Whitehouse, Kimberly Quaid, Tamsen Brown, Robert C. Green, and Norman R. Relkin. “Genetic Susceptibility Testing versus Family History-Based Risk Assessment: Impact on Perceived Risk of Alzheimer’s Disease.” Genetic Medicine 7 (2005): 48–53.

Latour, Bruno. Pandora’s Hope: Essays on the Reality of Science Studies. Cambridge, Mass.: Harvard University Press, 1999.

———. The Pasteurization of France. Cambridge, Mass.: Harvard University Press, 1988.

“Leading Edge: How Much Is Dementia Care Worth?” The Lancet Neurology 9, no. 11 (2010): 1037.

Leale, M. “The Senile Degenerations, Their Symptom-Complex and Treatment.” International Clinics 4 (1911): 37–47.

Lee, Virginia M.-Y. “Tauists and Baptists United—Well Almost!” Science 293 (2001): 1446–47.

Leibing, Annette, and Lawrence Cohen, eds. Thinking about Dementia: Culture, Loss, and the Anthropology of Senility. New Brunswick, N.J.: Rutgers University Press, 2006.

Levine, Judith. “Managing Dad.” In Ballenger et al., Treating Dementia, 116–24.

Lewontin, Richard C. “Science and Simplicity.” New York Review of Books 50 (2003): 39–42.

Libon, David J., Catherine C. Price, Kenneth M. Heilman, and Murray Grossman. “Alzheimer’s ‘Other Dementia.’ ” Cognitive and Behavioral Neurology 19, no. 2 (2006): 112–16.

Liddell, M. B., S. Lovestone, and M. J. Owen. “Genetic Risk of Alzheimer Disease: Advising Relatives.” British Journal of Psychiatry 178 (2001): 7–11.

Lin, Haiqun, Charles E. McCulloch, Bruce W. Turnbull, Elizabeth H. Slate, and Larry C. Clark. “A Latent Class Mixed Model for Analysing Biomarker Trajectories with Irregularly Scheduled Observations.” Statistics in Medicine 19, no. 10 (2000): 1303–18.

Lippa, Carol F., and John C. Morris. “Alzheimer Neuropathology in Nondemented Aging Keeping Mind over Matter.” Neurology 66, no. 12 (2006): 1801–2.

Lippman, Abby. “Led (Astray) by Genetic Maps: The Cartography of the Human Genome and Human Care.” Social Science & Medicine 35, no. 12 (1992): 1469–96.

Lishman, W. A. “The History of Research into Dementia and Its Relationship to Current Concepts.” In Huppert, Brayne, and O’Conner, Dementia and Normal Aging, 41–56.

Lock, Margaret. “The Alienation of Body Tissue and the Biopolitics of Immortalized Cell Lines.” Body & Society 7, nos. 2–3 (2001): 63–91.

———. “Centering the Household: The Remaking of Female Maturity in Japan.” In Re-Imagining Japanese Women, edited by Anne Imamura, 73–103. Berkeley: University of California Press, 1996.

———. Encounters with Aging: Mythologies of Menopause in Japan and North America. Berkeley: University of California Press, 1993. http://www.ucpress.edu/book.php?isbn=9780520201620.

———. “Interrogating the Human Genome Diversity Project.” Social Science & Medicine 39, no. 5 (1994): 603–6.

———. “The Lure of the Epigenome.” The Lancet 381 (2013) 1896–1897.

Lock, Margaret, Julia Freeman, Gillian Chilibeck, Briony Beveridge, and Miriam Padolsky. “Susceptibility Genes and the Question of Embodied Identity.” Medical Anthropology Quarterly 21, no. 3 (2007): 256–76.

Lock, Margaret, Julia Freeman, Rosemary Sharples, and Stephanie Lloyd. “When It Runs in the Family: Putting Susceptibility Genes in Perspective.” Public Understanding of Science 15, no. 3 (2006): 277–300.

Lock, Margaret, Stephanie Lloyd, and Janalyn Prest. “Genetic Susceptibility and Alzheimer Disease: The Penetrance and Uptake of Genetic Knowledge.” In Cohen and Leibing, Thinking about Dementia, 123–54.

Lock, Margaret M., and Vinh-Kim Nguyen. An Anthropology of Biomedicine. Oxford: Wiley-Blackwell, 2010.

Lock, Margaret, Allan Young, and Alberto Cambrosio, eds. Living and Working with the New Medical Technologies: Intersections of Inquiry. Cambridge: Cambridge University Press, 2000.

London, Alex John, and Jonathan Kimmelman. “Justice in Translation: From Bench to Bedside in the Developing World.” The Lancet 372 (2008): 82–85.

Lopez, Lorna M., Sarah E. Harris, Michelle Luciano, Dave Liewald, Gail Davies, Alan J. Gow, Albert Tenesa, et al. “Evolutionary Conserved Longevity Genes and Human Cognitive Abilities in Elderly Cohorts.” European Journal of Human Genetics 20, no. 3 (2012): 341–47.

Lumey, L. H. “Decreased Birthweights in Infants after Maternal in Utero Exposure to the Dutch Famine of 1944–1945.” Paediatric and Perinatal Epidemiology 6, no. 2 (1992): 240–53.

Lunn, Stephen. “End of Alzheimer’s Curse ‘a Decade Away.’ ” The Australian, September 19, 2001.

Mahley, R. W. “Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology.” Science 240 (1988): 622–30.

Mahley, R. W., K. H. Weisgraber, and Y. Huang. “Apolipoprotein E4: A Causative Factor and Therapeutic Target in Neuropathology, Including Alzheimer Disease.” Proceedings of the National Academy of Sciences 103, no. 15 (2006): 5644–51.

Mandavilli, Apoorva. “The Amyloid Code.” Nature Medicine 12, no. 7 (2006): 747–51.

Manolio, Teri A., Francis S. Collins, Nancy J. Cox, David B. Goldstein, Lucia A. Hindorff, David J. Hunter, Mark I. McCarthy, et al. “Finding the Missing Heritability of Complex Diseases.” Nature 461 (2009): 747–53.

Marks, Harry M. The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900–1990. Cambridge: Cambridge University Press, 1997.

Márquez, Gabriel García. One Hundred Years of Solitude. New York: HarperPerennial, 1991.

Martin, Paul M. V., and Estelle Martin-Granel. “2,500-Year Evolution of the Term Epidemic.” Emerging Infectious Diseases 12, no. 6 (2006): 976–80.

Massoud, Fadi, Gayatri Devi, Yaakov Stern, Arlene Lawton, James E. Goldman, Yan Liu, Steven S. Chin, and Richard Mayeux, “A Clinicopathological Comparison of Community-Based and Clinic-Based Cohorts of Patients with Dementia,” Archives of Neurology 56, no. 11 (1999): 1368–73.

Mastroeni, Diego, Andrew Grover, Elaine Delvaux, Charisse Whiteside, Paul D. Coleman, and Joseph Rogers. “Epigenetic Mechanisms in Alzheimer’s Disease.” Neurobiology of Aging 32, no. 7 (2011): 1161–80.

Mastroeni, Diego, Ann McKee, Andrew Grover, Joseph Rogers, and Paul D. Coleman. “Epigenetic Differences in Cortical Neurons from a Pair of Monozygotic Twins Discordant for Alzheimer’s Disease.” PLoS ONE 4, no. 8 (2009). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719870/.

Mattick, John S. “Challenging the Dogma: The Hidden Layer of Non-Protein-Coding RNAs in Complex Organisms.” BioEssays 25, no. 10 (2003): 930–39.

———. “The Hidden Genetic Program of Complex Organisms.” Scientific American 291, no. 4 (2004): 60–67.

Maurer, Konrad, and Ulrike Maurer. Alzheimer: The Life of a Physician and the Career of a Disease. New York: Columbia University Press, 1986.

Maurer, Konrad, Stephan Volk, and Hector Gerbaldo. “Auguste D: The History of Alois Alzheimer’s First Case.” In Whitehouse, Maurer, and Ballenger, Concepts of Alzheimer Disease, 20–29.

Maury, C.P.J. “The Emerging Concept of Functional Amyloid.” Journal of Internal Medicine 265, no. 3 (2009): 329–34.

Mayr, Ernst. “Cause and Effect in Biology.” Science 134 (1961): 1501–6.

McGeer, Edith G., and Pat L. McGeer. “Neuroinflammation: Alzheimer Disease, and Other Aging Disorders.” In Pharmacological Mechanisms in Alzheimer’s Therapeutics, edited by A. C. Cuello, 149–66. New York: Springer, 2007. http://dx.doi.org/10.1007/978-0-387-71522-3.

McGowan, Patrick O., Aya Sasaki, Ana C. D’Alessio, Sergiy Dymov, Benoit Labonté, Moshe Szyf, Gustavo Turecki, and Michael J. Meaney. “Epigenetic Regulation of the Glucocorticoid Receptor in Human Brain Associates with Childhood Abuse.” Nature Neuroscience 12, no. 3 (2009): 342–48.

McGowan, Patrick O., and Moshe Szyf. “The Epigenetics of Social Adversity in Early Life: Implications for Mental Health Outcomes.” Neurobiology of Disease 39, no. 1 (2010): 66–72.

McKeown, Thomas. The Modern Rise of Population. New York: Academic Press, 1976.

McKie, Robin. “Discovery of ‘Methuselah Gene’ Unlocks Secret of Long Life.” The Observer, February 3, 2002.

McMenemy, W. H. “Alzheimer’s Disease: Problems Concerning Its Concept and Nature.” Acta Neurologica Scandinavica 39 (1963): 369–80.

Medical Research Council. Senile and Presenile Dementias: A Report of the MRC Subcommittee, Compiled by W. A. Lishman. London: Medical Research Council, 1977.

Mercier, C. Sanity and Insanity. London: Walter Scott, 1895.

Mesulam, M. Marsel. “Neuroplasticity Failure in Alzheimer’s Disease: Bridging the Gap between Plaques and Tangles.” Neuron 24, no. 3 (1999): 521–29.

Michie, Susan, Harriet Drake, Theresa Marteau, and Martin Bobrow. “A Comparison of Public and Professionals’ Attitudes towards Genetic Developments.” Public Understanding of Science 4, no. 3 (1995): 243–53.

Midgley, Mary. Science and Poetry. London: Routledge, 2001.

Mintun, M. A., G. N. Larossa, Y. I. Sheline, C. S. Dence, S. Y. Lee, R. H. Mach, W. E. Klunk, C. A. Mathis, S. T. DeKosky, and J. C. Morris. “[11C]PIB in a Nondemented Population: Potential Antecedent Marker of Alzheimer Disease.” Neurology 67, no. 3 (2006): 446–52.

Mirowski, Philip, and Robert Van Horn. “The Contract Research Organization and the Commercialization of Scientific Research.” Social Studies of Science 35, no. 4 (2005): 503–48.

Mitchell, John J., Annie Capua, Carol Clow, and Charles R. Scriver. “Twenty-Year Outcome Analysis of Genetic Screening Programs for Tay-Sachs and Beta-Thalassemia Disease Carriers in High Schools.” American Journal of Human Genetics 59, no. 4 (1996): 793–98.

Mitchell, Sandra D. Unsimple Truths: Science, Complexity and Policy. Chicago: University of Chicago Press, 2009.

Miyagi, S., N. Iwama, T. Kawabata, and K. Hasegawa. “Longevity and Diet in Okinawa, Japan: The Past, Present and Future.” Asia-Pacific Journal of Public Health 15, suppl. (2003): S3–S9.

Möller, Hans-Jurgen, and Manuel B. Graeber. “Johann F.: The Historical Relevance of the Case for the Concept of Alzheimer Disease.” In Whitehouse, Maurer, and Ballenger, Concepts of Alzheimer Disease, 30–46.

Moreira, Tiago. “Truth and Hope in Drug Development and Evaluation in Alzheimer disease.” In Ballenger et al., Treating Dementia, 210–30.

Moreira, Tiago, Carl May, and John Bond. “Regulatory Objectivity in Action Mild Cognitive Impairment and the Collective Production of Uncertainty.” Social Studies of Science 39, no. 5 (2009): 665–90.

Moreira, Tiago, and Paolo Palladino. “Ageing between Gerontology and Biomedicine.” BioSocieties 4, no. 4 (2009): 349–65.

Morris, John C. “The Relationship of Plaques and Tangles to Alzheimer Disease Phenotype.” In Pathobiology of Alzheimer’s Disease, edited by Alison M. Goate and Frank Ashall, 193–218. London: Academic Press, 1995.

———. “Revised Criteria for Mild Cognitive Impairment May Compromise the Diagnosis of Alzheimer Disease Dementia.” Archives of Neurology 69, no. 6 (2012): 700–708.

Morris, John C., Catherine M. Roe, Elizabeth A. Grant, Denise Head, Martha Storandt, Alison M. Goate, Anne M. Fagan, David M. Holtzman, and Mark A. Mintun. “Pittsburgh Compound B Imaging and Prediction of Progression from Cognitive Normality to Symptomatic Alzheimer Disease.” Archives of Neurology 66, no. 12 (2009): 1469–75.

Morris, John C., Catherine M. Roe, Chengjie Xiong, Anne M. Fagan, Alison M. Goate, David M. Holtzman, and Mark A. Mintun. “APOE Predicts Aβ but Not Tau Alzheimer’s Pathology in Cognitively Normal Aging.” Annals of Neurology 67, no. 1 (2010): 122–31.

Mosammaparast, Nima, and Yang Shi. “Reversal of Histone Methylation: Biochemical and Molecular Mechanisms of Histone Demethylases.” Annual Review of Biochemistry 79 (2010): 155–79.

Mudher, Amritpal, and Simon Lovestone. “Alzheimer’s Disease—Do Tauists and Baptists Finally Shake Hands?” Trends in Neurosciences 25, no. 1 (2002): 22–26.

Mukherjee, Siddhartha. The Emperor of All Maladies: A Biography of Cancer. New York: Scribner, 2010.

Munir, Kerim, Suzanne Coulter, John H. Growdon, Ann MacDonald, Patrick J. Skerrett, and Jane A. Leopold. “How to Solve Three Puzzles.” Newsweek 151, no. 3 (January 21, 2008): 64–66.

Murphy, Tom. “Alzheimer’s Drug Fails Study but Flashes Potential.” Associated Press, August 24, 2012.

Nagy, Z., M. M. Esiri, K. A. Jobst, et al. “The Effects of Additional Pathology on the Cognitive Deficit in Alzheimer Disease.” Journal of Neuropathology & Experimental Neurology 56 (1997): 163–70.

Naj, Adam C., Gyungah Jun, Gary W. Beecham, Li-San Wang, Badri Narayan Vardarajan, Jacqueline Buros, Paul J. Gallins, et al. “Common Variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 Are Associated with Late-Onset Alzheimer’s Disease.” Nature Genetics 43, no. 5 (2011): 436–41.

Nascher, Ignatz. “Senile Mentality.” International Clinics 4 (1911): 48–59.

Nasreddine, Ziad S., Natalie A. Phillips, Valérie Bédirian, Simon Charbonneau, Victor Whitehead, Isabelle Collin, Jeffrey L. Cummings, and Howard Chertkow. “The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool for Mild Cognitive Impairment.” Journal of the American Geriatric Society 53, no. 4 (2005): 695–99.

National Institutes of Health. Alzheimer Disease Research Summit 2012: Path to Treatment and Prevention. Bethesda, Md.: National Institutes of Health, 2012. http://www.nia.nih.gov/about/events/2012/alzheimers-disease-research-summit-2012-path-treatment-and-prevention.

Nee, L. E., R. Eldridge, T. Sunderland, C. B. Thomas, D. Katz, K. E. Thompson, H. Weingartner, H. Weiss, C. Julian, and R. Cohen. “Dementia of the Alzheimer Type: Clinical and Family Study of 22 Twin Pairs.” Neurology 37, no. 3 (1987): 359–63.

Neumann-Held, Eva M., and Christopher Rehmann-Sutter. Genes in Development: Rereading the Molecular Paradigm. Durham, N.C.: Duke University Press, 2006.

Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study. “Pathological Correlates of Late-Onset Dementia in a Multicentre, Community-Based Population in England and Wales.” The Lancet 357 (2001): 169–75.

“New Alzheimer’s Genes Identified.” CBC News—Health, April 3, 2011. http://www.cbc.ca/news/health/story/2011/04/01/alzheimer-genes-identified.html.

Nichter, Mark. Global Health: Why Cultural Perceptions, Social Representations, and Biopolitics Matter. Tucson: University of Arizona Press, 2008.

Niewöhner, Jörg. “Epigenetics: Embedded Bodies and the Molecularization of Biography and Milieu.” BioSocieties 6 (2011): 279–98.

Niewöhner, Jörg, Martin Döring, Michalis Kontopodis, Jeannette Madarász, and Christoph Heintze, “Cardiovascular Disease and Obesity Prevention in Germany: An Investigation into a Heterogeneous Engineering Project,” Science, Technology & Human Values 36, no. 5 (2011): 723–51.

Noë, Alva. Out of Our Heads: Why You Are Not Your Brain and Other Lessons from the Biology of Consciousness. New York: Farrar, Straus and Giroux, 2009.

“Northern Ireland Dementia Total More Than Estimated.” BBC News, February 3, 2010. http://news.bbc.co.uk/2/hi/uk_news/northern_ireland/8494975.stm.

Novas, Carlos, and Nikolas Rose. “Genetic Risk and the Birth of the Somatic Individual.” Economy and Society 29, no. 4 (2000): 485–513.

Office of Public Affairs, University of California, Santa Barbara. “Clinical Trials for Alzheimer’s Disease Preventative Drug to Begin Early 2013.” News release, May 21, 2012. http://www.ia.ucsb.edu/pa/display.aspx?pkey=2734.

Ortega, Francisco, and Fernando Vidal, eds. Neurocultures: Glimpses into an Expanding Universe. Frankfurt: Peter Lang, 2011.

“Over the Mountain to Alzheimer’s.” Maclean’s, January 4, 2010. http://www2.macleans.ca/2010/01/04/over-the-mountain-to-alzheimers/.

Oyama, Susan, Paul E. Griffiths, and Russel D. Gray. Cycles of Contingency: Developmental Systems and Evolution, Life and Mind. Cambridge, Mass.: MIT Press, 2001.

Paradies, Yin C., Michael J. Montoya, and Stephanie M. Fullerton. “Racialized Genetics and the Study of Complex Diseases: The Thrifty Genotype Revisited.” Perspectives in Biology and Medicine 50, no. 2 (2007): 203–27.

Parra, Mario A., Sharon Abrahams, Robert H. Logie, Luis G. Méndez, Francisco Lopera, and Sergio Della Sala. “Visual Short-Term Memory Binding Deficits in Familial Alzheimer’s Disease.” Brain 133, no. 9 (2010): 2702–13.

Parry, Sarah, and John Dupré. “Introducing Nature After the Genome.” In Nature After the Genome, edited by Sarah Parry and John Dupré, 3–16. Oxford: Blackwell, 2010.

Patra, Prasanna Kumar, and Margaret Sleeboom-Faulkner. “Bionetworking: Experimental Stem Cell Therapy and Patient Recruitment in India.” Anthropology & Medicine 16, no. 2 (2009): 147–63.

Peine, Alexander. “Challenging Incommensurability: What We Can Learn from Ludwik Fleck and the Analysis of Configurational Innovation.” Minerva 49 (2011): 489–508.

Pepin, Jacques. The Origin of AIDS. Cambridge: Cambridge University Press, 2011.

Perry, Elaine K., Peter H. Gibson, Garry Blessed, Robert H. Perry, and Bernard E. Tomlinson. “Neurotransmitter Enzyme Abnormalities in Senile Dementia. Choline Acetyltransferase and Glutamic Acid Decarboxylase Activities in Necropsy Brain Tissue.” Journal of the Neurological Sciences 34, no. 2 (1977): 247–65.

Perry, Elaine K., Robert H. Perry, Peter H. Gibson, Garry Blessed, and Bernard E. Tomlinson. “A Cholinergic Connection between Normal Aging and Senile Dementia in the Human Hippocampus.” Neuroscience Letters 6, no. 1 (1977): 85–89.

Perry, George, Akihiko Nunomura, Arun K. Raina, and Mark A. Smith. “Amyloid-β Junkies.” The Lancet 355 (2000): 757.

Petersen, Ronald C. “The Current Status of Mild Cognitive Impairment—What Do We Tell Our Patients?” Nature Clinical Practice Neurology 3, no. 2 (2007): 60–61.

———, ed. Mild Cognitive Impairment: Aging to Alzheimer’s Disease. Oxford: Oxford University Press, 2003.

———. “Mild Cognitive Impairment Is Relevant.” Philosophy, Psychiatry, & Psychology 13, no. 1 (2006): 45–49.

Petersen, Ronald C., Rachelle Doody, Alexander Kurz, Richard C. Mohs, John C. Morris, Peter V. Rabins, Karen Ritchie, Martin Rossor, Leon Thal, and Bengt Winblad. “Current Concepts in Mild Cognitive Impairment.” Archives of Neurology 58, no. 12 (2001): 1985–92.

Petersen, Ronald C., Stephen C. Waring, Glenn E. Smith, Eric G. Tangalos, and Stephen N. Thibodeau. “Predictive Value of APOE Genotyping in Incipient Alzheimer’s Disease.” Annals of the New York Academy of Sciences 802, no. 1 (1996): 58–69.

Petronis, A. “Human Morbid Genetics Revisited: Relevance of Epigenetics.” Trends in Genetics 17, no. 3 (2001): 142–46.

Petryna, Adriana. “Clinical Trials Offshored: On Private Sector Science and Public Health.” BioSocieties 2, no. 1 (March 2007): 21–40.

Pickersgill, Martyn, Sarah Cunningham-Burley, and Paul Martin. “Constituting Neurologic Subjects: Neuroscience, Subjectivity and the Mundane Significance of the Brain.” Subjectivity 4 (2011): 346–65.

Pike, Kerryn E., Greg Savage, Victor L. Villemagne, Steven Ng, Simon A. Moss, Paul Maruff, Chester A. Mathis, William E. Klunk, Colin L. Masters, and Christopher C. Rowe. “Β-amyloid Imaging and Memory in Non-demented Individuals: Evidence for Preclinical Alzheimer’s Disease.” Brain 130, no. 11 (2007): 2837–44.

Pimplikar, Sanjay W. “Alzheimer’s Isn’t Up to the Tests.” New York Times, July 19, 2010, Opinion sec. http://www.nytimes.com/2010/07/20/opinion/20pimplikar.html.

Pollack, Andrew. “Alzheimer’s Drug Fails Its First Big Clinical Trial.” New York Times, July 23, 2012.

Post, S. G., P. J. Whitehouse, R. H. Binstock, T. D. Bird, S. K. Eckert, L. A. Farrer, L. M. Fleck, et al. “The Clinical Introduction of Genetic Testing for Alzheimer Disease: An Ethical Perspective.” Journal of the American Medical Association 277, no. 10 (1997): 832–36.

Powers, Evan T., Richard I. Morimoto, Andrew Dillin, Jeffery W. Kelly, and William E. Balch. “Biological and Chemical Approaches to Diseases of Proteostasis Deficiency.” Annual Review of Biochemistry 78 (2009): 959–91.

Prainsack, Barbara, and Gil Siegal. “The Rise of Genetic Couplehood? A Comparative View of Premarital Genetic Testing.” BioSocieties 1, no. 1 (2006): 17–36.

Price, Joseph L., Daniel W. McKeel Jr., Virginia D. Buckles, Catherine M. Roe, Chengjie Xiong, Michael Grundman, Lawrence A. Hansen, et al. “Neuropathology of Nondemented Aging: Presumptive Evidence for Preclinical Alzheimer Disease.” Neurobiology of Aging 30, no. 7 (2009): 1026–36.

Prince, Martin, Daisy Acosta, Helen Chiu, Marcia Scazufca, and Mathew Varghese. “Dementia Diagnosis in Developing Countries: A Cross-Cultural Validation Study.” Lancet 361 (2003): 909–17.

Prince, Martin, Renata Bryce, Emiliano Albanese, Anders Wimo, Wagner Ribeiro, Cleusa P. Ferri. “The Global Prevalence of Dementia: A Systematic Review and Metaanalysis.” Alzheimer’s and Dementia 9 (2013): 63–75.

Purdy, Michael C. “Investigational Drugs Chosen for Major Alzheimer’s Prevention Method.” Washington University in St. Louis, 2012. http://www.wustel.edu.

Quaid, Kimberley A., and Michael Morris. “Reluctance to Undergo Predictive Testing: The Case of Huntington Disease.” American Journal of Medical Genetics 45, no. 1 (1993): 41–45.

Quiroz, Yakeel T., Andrew E. Budson, Kim Celone, Adriana Ruiz, Randall Newmark, Gabriel Castrillón, Francisco Lopera, and Chantal E. Stern. “Hippocampal Hyperactivation in Presymptomatic Familial Alzheimer’s Disease.” Annals of Neurology 68, no. 6 (2010): 865–75.

Rabinow, Paul. “Afterword: Concept Work.” In Gibbon and Novas, Biosocialities, Genetics and the Social Sciences, 188–92.

———. “Artificiality and Enlightenment: From Sociobiology to Biosociality.” In Essays on the Anthropology of Reason, 91–111. Princeton: Princeton University Press, 1996.

Raeburn, Paul. “NY Times Strangely Quiet on Alzheimer’s Test That ‘Can Be 100 Percent Accurate.’ ” Knight Science Journalism at MIT, January 21, 2011. http://ksj.mit.edu/tracker/2011/01/ny-times-strangely-quiet-alzheimers-test.

Raiha, I., J. Kaprio, M. Koskenvuo, T. Rajala, and L. Sourander. “Alzheimer’s Disease in Finnish Twins.” Lancet 347 (1996): 573–78.

Rapp, Rayna. “Cell Life and Death, Child Life and Death: Genomic Horizons, Genetic Diseases, Family Stories.” In Remaking Life and Death: Toward an Anthropology of the Biosciences, edited by Sarah Franklin and Margaret Lock, 23–60. Santa Fe, N.Mex.: School of American Research Press, 2004.

———. Testing Women, Testing the Fetus: The Social Impact of Amniocentesis. New York: Routledge, 1999.

Rapp, Rayna, Deborah Heath, and Karen-Sue Taussig. “Genealogical Disease: Where Hereditary Abnormality, Biomedical Explanation, and Family Responsibility Meet.” In Relative Matters: New Directions in the Study of Kinship, edited by Sarah Franklin and Susan MacKinnon, 384–412. Durham, N.C.: Duke University Press, 2001.

Redlich, F. C. “The Concept of Health in Psychiatry.” In Explorations in Social Psychiatry, edited by Alexander H. Leighton, J. N. Clausen, and R. N. Wilson, 138–64. New York: Basic Books, 1957.

Reiman, Eric, Francisco Lopera, Jessica Langbaum, Adam Fleisher, Naparkamon Ayutyanont, Yakeel Quiros, Laura Jakimovitch, Carolyn Langlois, and Pierre Tariot. “The Alzheimer’s Prevention Initiative.” Alzheimer’s & Dementia 8, no. 4 (2012): 427.

Reiman, Eric, Yakeel T. Quiroz, Adam S. Fleisher, Kewei Chen, Carlos Velez-Pardo, Marlene Jimenez-Del-Rio, Anne M. Fagan, Aarti R. Shah, Sergio Alvarez, Andrés Arbelaez, Margarita Giraldo, Natalia Acosta-Baena, Reisa A. Sperling, Brad Dickerson, Chantal E. Stern, Victoria Tirado, Claudia Munoz, Rebecca A. Reiman, Matthew J. Huentelman, Gene E. Alexander, Jessica B. S. Langbaum, Kenneth S. Kosik, Pierre N. Tariot, and Francisco Lopera. “Brain Imaging and Fluid Biomarker Analysis in Young Adults at Genetic Risk for Autosomal Dominant Alzheimer’s Disease in the Presenilin 1 E280A Kindred: A Case-Control Study.” The Lancet Neurology 11 (2012): 1048–56.

Rheinberger, Hans-Jorg “Beyond Nature and Culture: modes of reasoning in the age of molecular biology and medicine.” In Lock, Young, and Cambrosio, Living and Working with the New Medical Technologies, 19–30.

Relkin, Norman R. “Apolipoprotein E Genotyping in Alzheimer’s Disease.” The Lancet 347 (1996): 1091–95.

Relkin, Norman R., Younga J. Kwon, Julia Tsai, and Samuel Gandy. “The National Institute on Aging/Alzheimer’s Association Recommendations on the Application of Apolipoprotein E Genotyping to Alzheimer’s Disease.” Annals of the New York Academy of Sciences 802, no. 1 (1996): 149–76.

Reynolds, Susan. Questioning Misfortune: The Pragmatics of Uncertainty in Eastern Uganda. Cambridge: Cambridge University Press, 1997.

Rheinberger, Hans-Jörg. “Beyond Nature and Culture: Modes of Reasoning in the Age of Molecular Biology and Medicine.” In Lock, Young, and Cambrosio, Living and Working with the New Medical Technologies, 19–30.

Richards, Marcus, and Carol Brayne. “What Do We Mean by Alzheimer Disease?” British Medical Journal 341 (2010): 865–67.

Richards, Martin. “Lay and Professional Knowledge of Genetics and Inheritance.” Public Understanding of Science 5, no. 3 (1996): 217–30.

Ritchie, K., and A. M. Dupuy. “The Current Status of APOε4 as a Risk Factor for Alzheimer’s Disease: An Epidemiological Perspective.” International Journal of Geriatric Psychiatry 14, no. 9 (1999): 695–700.

Ritchie, K., D. Leibovici, B. Lessert, and J. Touchon. “A Typology of Sub-clinical Senescent Cognitive Disorder.” British Journal of Psychiatry 168 (1966): 470–76.

Roberts, J. S., K. D. Christensen, and R. C. Green. “Using Alzheimer’s Disease as a Model for Genetic Risk Disclosure: Implications for Personal Genomics.” Clinical Genetics 80, no. 5 (2011): 407–14.

Robertson, Jennifer. “Robo Sapiens Japanicus: Humanoid Robots and the Posthuman Family.” Critical Asian Studies 39, no. 3 (2007): 369–98.

Román, Gustavo C., and Donald R. Royall. “Executive Control Function: A Rational Basis for the Diagnosis of Vascular Dementia.” Alzheimer Disease & Associated Disorders 13 (1999): S4–S8.

Rose, Nikolas. The Politics of Life Itself: Biomedicine, Power, and Subjectivity in the Twenty-First Century. Princeton: Princeton University Press, 2006.

Rosenberg, Charles E. “The Tyranny of Diagnosis: Specific Entities and Individual Experience.” Milbank Quarterly 80, no. 2 (2002): 237–60.

———. “What Is Disease? In Memory of Owsei Temkin.” Bulletin of the History of Medicine 77, no. 3 (2003): 491–505.

Roses, Allen D. “Apolipoprotein E and Alzheimer’s Disease: A Rapidly Expanding Field with Medical and Epidemiological Consequences.” Annals of the New York Academy of Sciences 802, no. 1 (1996): 50–57.

———. “Apolipoprotein E and Alzheimer’s Disease: The Tip of the Susceptibility Iceberg.” Annals of the New York Academy of Sciences 855, no. 1 (1998): 738–43.

Roth, Martin. “Dementia and Normal Aging of the Brain.” In Huppert, Brayne, and O’Conner, Dementia and Normal Aging, 57–76.

Roth, Martin, Bernard E. Thomlinson, and Gary Blessed. “Correlation between Scores for Dementia and Counts of Senile Plaques in Cerebral Grey Matter of Elderly Subjects.” Nature 209 (1966): 109–10.

Rothschild, David. “The Practical Value of Research in the Psychoses of Later Life.” Diseases of the Nervous System 8, no. 4 (1947): 123–28.

Runciman, David. “Will We Be All Right in the End?” London Review of Books 34, no. 1 (2012): 3–5.

Sato, Ashida, Laura M. Koehly, J. Scott Roberts, Clara A. Chen, Susan Hiraki, and Robert C. Green. “Disclosing the Disclosure: Factors Associated with Communicating the Results of Genetic Susceptibility Testing for Alzheimer’s Disease.” Journal of Health Communication 14, no. 8 (2009): 768–84.

Saunders, A. M., W. J. Strittmatter, D. Schmechel, P. H. St George-Hyslop, M. A. Pericak-Vance, S. H. Joo, B. L. Rosi, J. F. Gusella, D. R. Crapper-MacLachlan, and M. J. Alberts. “Association of Apolipoprotein E Allele Epsilon 4 with Late-Onset Familial and Sporadic Alzheimer’s Disease.” Neurology 43, no. 8 (1993): 1467–72.

Savva, George M., Stephen B. Wharton, Paul G. Ince, Gillian Forster, Fiona E. Matthews, and Carol Brayne. “Age, Neuropathology, and Dementia.” New England Journal of Medicine 360, no. 22 (2009): 2302–9.

Schiffman, Mark, Nicolas Wentzensen, Sholom Wacholder, Walter Kinney, Julia C. Gage, and Philip E. Castle. “Human Papillomavirus Testing in the Prevention of Cervical Cancer.” Journal of the National Cancer Institute 103, no. 5 (2011): 368–83.

Schipper, Hyman M. “Presymptomatic Apolipoprotein E Genotyping for Alzheimer’s Disease Risk Assessment and Prevention.” Alzheimer’s & Dementia 7, no. 4 (2011): e118–e123.

Schneider, Julie A., Zoe Arvanitakis, Woojeong Bang, and David A. Bennett. “Mixed Brain Pathologies Account for Most Dementia Cases in Community-Dwelling Older Persons.” Neurology 69, no. 24 (2007): 2197–2204.

Schneider, Julie A., Zoe Arvanitakis, Sue E. Leurgans, and David A. Bennett. “The Neuropathology of Probable Alzheimer Disease and Mild Cognitive Impairment.” Annals of Neurology 66, no. 2 (2009): 200–208.

Scinto, Leonard F. M., and Kirk R. Daffner, eds. The Early Diagnosis of Alzheimer’s Disease. Totowa, N.J.: Humana Press, 2000.

Scriver, C. R., and P. J. Waters. “Monogenic Traits Are Not Simple: Lessons from Phenylketonuria.” Trends in Genetics 15, no. 7 (1999): 267–72.

Segelken, Roger H. “Alzheimer Activist.” New York Times, September 24, 2008.

Selkoe, Dennis J. “The Pathophysiology of Alzheimer’s Disease.” In Scinto and Daffner, The Early Diagnosis of Alzheimer’s Disease, 83–104.

Serematakis, Nadia C. The Last Word: Women, Death, and Divination in Inner Mani. Chicago: University of Chicago Press, 1991.

Shah, Yogesh. “Gray Tsunami: Challenges and Solutions of Global Aging.” DMU Magazine, Summer 2011. http://www.dmu.edu/magazine/summer-2011/my-turn-summer-2011/gray-tsunami-challenges-and-solutions-of-global-aging/.

Sheriff, Natasija. “Dental Health Linked to Risk of Developing Dementia.” Globe and Mail, August 22, 2012.

Shi, Hui, Christopher Medway, James Bullock, Kristelle Brown, Noor Kalsheker, and Kevin Morgan. “Analysis of Genome-Wide Association Study (GWAS) Data Looking for Replicating Signals in Alzheimer’s Disease (AD).” International Journal of Molecular Epidemiology and Genetics 1, no. 1 (2009): 53–66.

Siegmund, Kimberly D., Caroline M. Connor, Mihaela Campan, Tiffany I. Long, Daniel J. Weisenberger, Detlev Biniszkiewicz, Rudolf Jaenisch, Peter W. Laird, and Schahram Akbarian. “DNA Methylation in the Human Cerebral Cortex Is Dynamically Regulated throughout the Life Span and Involves Differentiated Neurons.” PLoS ONE 2, no. 9 (2007). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1964879/.

Simchowicz, T. “Histologische Studien über die senile Demenz.” In Histologische und histopathologische Arbeiten, vol. 4, edited by F. Nissl and A. Alzheimer, 267–444. Jena: Fischer, 1913.

Slaby, Jan. “Steps towards a Critical Neuroscience.” Phenomenology and the Cognitive Sciences 9, no. 3 (2010): 397–416.

Small, G. W., S. Komo, A. La Rue, S. Saxena, M. E. Phelps, J. C. Mazziotta, A. M. Saunders, J. L. Haines, M. A. Pericak-Vance, and A. D. Roses. “Early Detection of Alzheimer’s Disease by Combining Apolipoprotein E and Neuroimaging.” Annals of the New York Academy of Sciences 802 (1996): 70–78.

Smith, Eric E., and Steven M. Greenberg. “Beta-Amyloid, Blood Vessels and Brain Function.” Stroke 40, no. 7 (2009): 2601–6.

Smith, Glenn E., Ronald C. Petersen, Joseph E. Parisi, Robert J. Ivnik, Emre Kokmen, Eric G. Tangalos, and Stephen Waring. “Definition, Course, and Outcome of Mild Cognitive Impairment.” Aging, Neuropsychiatry and Cognition 3 (1996): 141–47.

Snowdon, David. “Aging and Alzheimer Disease: Lessons from the Nun Study.” The Gerontologist 35 (1997): 150–56.

———. Aging with Grace: What the Nun Study Teaches Us about Leading Longer, Healthier and More Meaningful Lives. New York: Bantam Books, 2001.

Sontag, Estelle, Christa Hladik, Lisa Montgomery, Ampa Luangpirom, Ingrid Mudrak, Egon Ogris, and Charles L. White III. “Downregulation of Protein Phosphatase 2A Carboxyl Methylation and Methyltransferase May Contribute to Alzheimer Disease Pathogenesis.” Journal of Neuropathology & Experimental Neurology 63, no. 10 (2004): 1080–91.

Soscia, Stephanie J., James E. Kirby, Kevin J. Washicosky, Stephanie M. Tucker, Martin Ingelsson, Bradley Hyman, Mark A. Burton, et al. “The Alzheimer’s Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide.” PLoS ONE 5, no. 3 (2010): e9505.

Sperling, Reisa A., Paul S. Aisen, Laurel A. Beckett, David A. Bennett, Suzanne Craft, Anne M. Fagan, Takeshi Iwatsubo, et al. “Toward Defining the Preclinical Stages of Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease.” Alzheimer’s & Dementia 7, no. 3 (2011): 280–92.

Sperling, Reisa A., and Scott Roberts. “Disclosure of Amyloid Status in Secondary Prevention Trials for Alzheimer’s Disease.” Alzheimer’s & Dementia 8, no. 4 (2012): 423.

Stanford, P. K. Exceeding Our Grasp: Science, History and the Problem of Unconceived Alternatives. New York: Oxford University Press, 2006.

Star, Susan Leigh. “Cooperation without Consensus in Scientific Problem Solving: Dynamics of Closure in Open Systems.” In CSCW: Cooperation or Conflict?, edited by Steve Easterbrook, 93–106. London: Springer, 1993.

Steenhuysen, Julie. “Roche Alzheimer’s Drug Picked for Major Test.” Reuters, May 15, 2012. http://www.reuters.com/article/2012/05/15/us-alzheimers-genentech-idUSBRE84E0UJ20120515.

Stix, Gary. “Obama’s War on Alzheimer’s: Will We Be Able to Treat the Disease by 2025?” Scientific American, January 31, 2012. http://blogs.scientificamerican.com/observations/2012/01/31/obamas-war-on-alzheimers-will-we-be-able-to-treat-the-disease-by-2025/.

Storandt, Martha, Mark A. Mintun, Denise Head, and John C. Morris. “Cognitive Decline and Brain Volume Loss Are Signatures of Cerebral Aβ Deposition Identified with PIB.” Archives of Neurology 66, no. 12 (2009): 1476–81.

Stotz, Karola, Adam Bostanci, and Paul Griffiths. “Tracking the Shift to ‘Postgenomics.’ ” Community Genetics 9, no. 3 (2006): 190–96.

Strittmatter, W. J., D. Y. Huang, R. Bhasin, A. D. Roses, and D. Goldgaber. “Avid Binding of Beta A Amyloid Peptide to Its Own Precursor.” Experimental Neurology 122, no. 2 (1993): 327–34.

Strobel, Gabrielle. “Paper Alert: GWAS Hits Clusterin, CR1, PICALM Formally Published.” Alzheimer Research Forum, September 7, 2009. http://www.alzforum.org/new/detail.asp?id=2233.

Strohman, R. “A New Paradigm for Life: Beyond Genetic Determinism.” California Monthly 111 (2001): 4–27.

Sullivan, Michele G. “Studies Take Aim at Groups at High Risk for Alzheimer’s.” WorldCare Clinical, March 21, 2011.

Swartz, R. H., S. E. Black, and P. St George-Hyslop. “Apolipoprotein E and Alzheimer’s Disease: A Genetic, Molecular and Neuroimaging Review.” Canadian Journal of Neurological Sciences 26, no. 2 (1999): 77–88.

Szyf, Moshe. “The Early Life Social Environment and DNA Methylation: DNA Methylation Mediating the Long-Term Impact of Social Environments Early in Life.” Epigenetics 8 (2011): 971–78.

Szyf, Moshe, Patrick McGowan, and Michael J. Meaney. “The Social Environment and the Epigenome.” Environmental and Molecular Mutagenesis 49, no. 1 (2008): 46–60.

Taussig, Karen-Sue, Rayna Rapp, and Deborah Heath. “Flexible Eugenics: Technologies of the Self in the Age of Genetics.” In Goodman, Heath, and Lindee, Genetic Nature/Culture, 58–76.

Tedde, Andrea, Benedetta Nacmias, Monica Ciantelli, Paolo Forleo, Elena Cellini, Silvia Bagnoli, Carolina Piccini, Paolo Caffarra, Enrico Ghidoni, Marco Paganini, Laura Bracco, and Sandro Sorbi. “Identification of New Presenilin Gene Mutations in Early-Onset Familial Alzheimer Disease.” Archives of Neurology 60, no. 11 (2003): 1541–44.

Templeton, Alan R. “The Complexity of the Genotype-Phenotype Relationship and the Limitations of Using Genetic ‘Markers’ at the Individual Level.” Science in Context 11, nos. 3–4 (1998): 373–89.

Teng, E. L., and H. C. Chui. “The Modified Mini-Mental State (3MS) Examination.” Journal of Clinical Psychiatry 48, no. 8 (1987): 314–18.

Tilley, L., K. Morgan, and N. Kalsheker. “Genetic Risk Factors in Alzheimer’s Disease.” Molecular Pathology 51, no. 6 (1998): 293–304.

Torack, Richard M. The Pathologic Physiology of Dementia, with Indications for Diagnosis and Treatment. Berlin: Springer-Verlag, 1978.

Traphagan, John W. Taming Oblivion: Aging Bodies and the Fear of Senility in Japan. Albany: State University of New York Press, 2000.

Turney, J. “The Public Understanding of Science—Where Next?” European Journal of Genetics in Society 1, no. 2 (1995): 5–22.

“2008 Alzheimer’s Disease Facts and Figures.” Alzheimer’s & Dementia 4, no. 2 (2008): 110–33.

United Nations Department of Economic and Social Affairs, Population Division. World Population Ageing: 1950–2050. 2002. http://www.un.org/esa/population/publications/worldageing19502050/.

Victoroff, J., W. J. Mack, S. A. Lyness, and H. C. Chui. “Multicenter Clinicopathological Correlation in Dementia.” American Journal of Psychiatry 152, no. 10 (1995): 1476–84.

Von Dras, D. D., and H. T. Blumenthal. “Dementia of the Aged: Disease or Atypical-Accelerated Aging? Biopathological and Psychological Perspectives.” Journal of the American Geriatrics Society 40, no. 3 (1992): 285–94.

Waalen, Jill, and Ernest Beutler. “Genetic Screening for Low-Penetrance Variants in Protein-Coding Genes.” Annual Review of Genomics and Human Genetics 10 (2009): 431–50.

Wadman, Meredith. “Fleshing Out the US Alzheimer’s Strategy.” Nature News, January 19, 2012. http://www.nature.com/news/fleshing-out-the-us-alzheimer-s-strategy-1.9856.

Wadman, Meredith, and Nature Magazine. “U.S. Government Sets Out Alzheimer’s Plan.” Scientific American, May 23, 2012. http://www.scientificamerican.com/article.cfm?id=us-government-sets-alzheimers-plan.

Wailoo, Keith, and Stephen Pemberton. The Troubled Dream of Genetic Medicine: Ethnicity and Innovation in Tay-Sachs, Cystic Fibrosis, and Sickle Cell Disease. Baltimore: Johns Hopkins University Press, 2006.

Wang, Sun-Chong, Beatrice Oelze, and Axel Schumacher. “Age-Specific Epigenetic Drift in Late-Onset Alzheimer’s Disease.” PLoS ONE 3, no. 7 (2008): e2698.

Waters, C. K. “Causes That Make a Difference.” Journal of Philosophy 104 (2007): 551–79.

Weiner, Jonathan. The Beak of the Finch. New York: Vintage Books, 1994.

Weiner, Michael W., Paul S. Aisen, Clifford R. Jack Jr., William J. Jagust, John Q. Trojanowski, Leslie Shaw, Andrew J. Saykin, et al. “The Alzheimer’s Disease Neuroimaging Initiative: Progress Report and Future Plans.” Alzheimer’s & Dementia 6, no. 3 (2010): 202–11.

Weiss, Kenneth M., and Anne V. Buchanan. “Is Life Law-Like?” Genetics 188, no. 4 (2011): 761–71.

———. The Mermaid’s Tale: Four Billion Years of Cooperation in the Making of Living Things. Cambridge, Mass.: Harvard University Press, 2009.

Wenk, G. L. “Neuropathologic Changes in Alzheimer’s Disease.” Journal of Clinical Psychiatry 64 (2003): 7–10.

Wexler, Alice. Mapping Fate: A Memoir of Family Risk and Genetic Research. Berkeley: University of California Press, 1995.

Whitehouse, Peter J. “Can We Fix This with a Pill? Qualities of Life and the Aging Brain.” In Ballenger et al., Treating Dementia, 168–82.

———. “Mild Cognitive Impairment—A Confused Concept?” Nature Clinical Practice Neurology 3, no. 2 (2007): 62–63.

Whitehouse, Peter J., and Daniel George. The Myth of Alzheimer’s: What You Aren’t Being Told about Today’s Most Dreaded Diagnosis. New York: St. Martin’s, 2008.

Whitehouse, Peter J., Konrad Maurer, and Jesse F. Ballenger, eds. Concepts of Alzheimer Disease: Biological, Clinical, and Cultural Perspectives. Baltimore: Johns Hopkins University Press, 2000.

Whitehouse, Peter J., Donald L. Price, Arthur W. Clark, Joseph T. Coyle, and Mahlon R. DeLong. “Alzheimer Disease: Evidence for Selective Loss of Cholinergic Neurons in the Nucleus Basalis.” Annals of Neurology 10, no. 2 (1981): 122–26.

Whyte, Susan Reynolds. Questioning Misfortune: The Pragmatics of Uncertainty in Eastern Uganda. Cambridge: Cambridge University Press, 1997.

Wilkinson, Alec. “The Lobsterman.” The New Yorker, July 31, 2006, 56–65.

Winblad, B., K. Palmer, M. Kivipelto, V. Jelic, L. Fratiglioni, L.-O. Wahlund, A. Nordberg, et al. “Mild Cognitive Impairment—Beyond Controversies, towards a Consensus: Report of the International Working Group on Mild Cognitive Impairment.” Journal of Internal Medicine 256, no. 3 (2004): 240–46.

Winnefeld, Marc, and Frank Lyko. “The Aging Epigenome: DNA Methylation from the Cradle to the Grave.” Genome Biology 13, no. 7 (2012): 165–68.

Wisniewski, H. M., A. Rabe, W. Silverman, and W. Zigman. “Neuropathological Diagnosis of Alzheimer Disease: A Survey of Current Practices.” Alzheimer Disease & Associated Disorders 2, no. 4 (1988): 396–414.

Yang, Benjamin. “A United Disease Theory Brings Two Groups of Alzheimer’s Disease Researchers Together.” Discovery Medicine, May 10, 2009. http://www.discoverymedicine.com/Benjamin-Yang/2009/05/10/a-united-disease-theory-brings-two-groups-of-alzheimer-researchers-together/.

Yasuda, Kazuki, Kazuaki Miyake, Yukio Horikawa, Kazuo Hara, Haruhiko Osawa, Hiroto Furuta, Yushi Hirota, et al. “Variants in KCNQ1 Are Associated with Susceptibility to Type 2 Diabetes Mellitus.” Nature Genetics 40, no. 9 (2008): 1092–97.

Yip, Agustin G., Carol Brayne, and Fiona E. Matthews. “Risk Factors for Incident Dementia in England and Wales: The Medical Research Council Cognitive Function and Ageing Study. A Population-Based Nested Case-Control Study.” Age and Ageing 35, no. 2 (2006): 154–60.

Yong, Ed. “Life Begins at 100: Secrets of the Centenarians.” Mind Power News, 2009. http://www.mindpowernews.com/LifeBeginsAt100.htm.

Yoxen, Edward J. “Constructing Genetic Diseases.” In The Problem of Medical Knowledge: Examining the Social Construction of Medicine, edited by P. Wright and A. Treacher, 144–61. Edinburgh: University of Edinburgh, 1982.

Zhang, Hong. “Who Will Care for Our Parents? Changing Boundaries of Family and Public Roles in Providing Care for the Aged in China.” Journal of Long-Term Home Health Care 25 (2007): 39–46.

Zheng, Wei, Jirong Long, Yu-Tang Gao, Chun Li, Ying Zheng, Yong-Bin Xiang, Wanqing Wen, et al. “Genome-wide Association Study Identifies a New Breast Cancer Susceptibility Locus at 6q25.1.” Nature Genetics 41, no. 3 (2009): 324–28.

Zuk, Or, Eliana Hechter, Shamil R. Sunyaev, and Eric S. Lander. “The Mystery of Missing Heritability: Genetic Interactions Create Phantom Heritability.” Proceedings of the National Academy of Sciences, December 5, 2011. http://www.pnas.org/content/early/2012/01/04/1119675109.